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ABSTRACT 
 
 Staphylococcus spp. are important causes of skin and systemic infections in 
people, dogs, and horses. In dogs, S. pseudintermedius is the most common cause of 
pyoderma. Staphylococcus aureus exfoliative toxin (ET) genes are associated with 
blistering skin lesions, and four purported exfoliative toxin genes have been reported in S. 
pseudintermedius: speta, siet, expA, and expB. Few studies have determined the 
prevalence of S. pseudintermedius ET genes in a large collection of canine isolates, and 
none have induced native ET proteins or determined if dogs produce anti-ET antibodies. 
The prevalence of speta, siet, expA, and expB in a collection of 500 clinical isolates from 
healthy and diseased dogs was 100, 99, 13, and 16%, respectively. A higher proportion of 
the dogs with pyoderma cultured expA-positive isolates when compared to healthy and 
diseased dogs. Native induction of EXPA and EXPB required incubation of liquid cultures 
with 10% CO2, and both proteins were excreted in the culture supernatant. The SIET 
protein was not detected under these conditions. Canine sera contained antibodies against 
EXPA and EXPB. Whole genome sequencing was performed on a subset of 13 isolates. 
In the genomic sequences we obtained, the expA gene was consistently carried adjacent to 
a reverse transcriptase (Group II intron) and expB next to mobile element proteins that 
may facilitate horizontal transfer of the genes.  
 Staphylococcus aureus is associated with soft tissue and respiratory infections in 
horses. No studies have examined toxin and antimicrobial resistance characteristics of 
equine methicillin-sensitive (MSSA) and resistant (MRSA) isolates from the southern 
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United States (US). The MRSA prevalence in a collection of 71 clinical isolates from 
horses and donkeys was 19%, with most being clonal complex 8. The most common 
MSSA was ST1, and 66% of all isolates carried the equine-adapted leucocidin PQ, the 
first instance of carriage outside of Europe. The toxin and resistance genes carried were 
diverse and included a new prophage-encoded variant of toxic shock syndrome toxin and 
one mupirocin and lincosamide-resistant isolate that has never been reported in a horse. 
We found that MSSA in addition to MRSA carry diverse virulence factors and can be 
pathogenic in horses. 
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NOMENCLATURE 
 
ACME Arginine catabolic mobile element 
EDIN Epidermal cell differentiation inhibitor 
ET Exfoliative toxin 
FFPE Formalin-fixed paraffin embedded 
IEC Immune evasion cluster 
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MRSA Methicillin-resistant Staphylococcus aureus 
MRSP Methicillin-resistant Staphylococcus pseudintermedius 
MSSA Methicillin sensitive Staphylococcus aureus 
MSSP Methicillin sensitive Staphylococcus pseudintermedius 
PI Pathogenicity island 
SAgs Superantigens 
SCCmec Staphylococcal cassette chromosome mec  
ST Sequence type 
VMTH Veterinary Medical Teaching Hospital 
WGS Whole genome sequencing 
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CHAPTER I  
INTRODUCTION  
 
Background 
Little is known about the carriage prevalence of S. pseudintermedius exfoliative 
toxin (ET) genes, if the genes can be horizontally transferred, or if carriage of ET genes is 
associated with patient demographics, predominate strain types or specific antimicrobial 
susceptibility profiles. Likewise, expression of native ET in S. pseudintermedius isolates 
with different ET carriage profiles has not been investigated. The complete toxin gene 
carriage profiles, strain type, and antimicrobial susceptibilities of equine S. aureus isolates 
collected from the southern United States (US) have also not been studied. To address 
these questions, the dissertation is divided into four aims, each comprising a chapter of the 
dissertation. 
 
Specific Aims 
AIM 1: Determine the prevalence of exfoliative toxin (ET) gene carriage in 
Staphylococcus pseudintermedius isolated from dogs. Determine if there are correlations 
between ET gene carriage, patient demographics, infection site, or methicillin resistance 
status. Determine if ET gene carriage is correlated to inflammation severity in canine skin 
biopsies. 
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AIM 2: Induce native expression of the EXPA and EXPB toxin proteins in 
bacterial isolates in vitro. Determine if dogs with and without a history of pyoderma or 
culture of S. pseudintermedius produce antibodies to the ET expA and expB. 
AIM 3: Perform whole genome sequencing (Illumina MiSeq and Oxford 
Nanopore) on select Staphylococcus pseudintermedius isolates carrying specific ET genes 
to map the positions of the ET genes within the chromosome and determine if ET genes 
are integrated on mobile genetic elements (MGE).  
AIM 4: Perform whole genome sequencing (Illumina MiSeq) on Staphylococcus 
aureus isolates from horses admitted to the Veterinary Medical Teaching Hospital.  
Determine the prevalence of toxin gene carriage in the isolates and if there are correlations 
between toxin gene carriage, patient demographics, infection site, or methicillin resistance 
status. 
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CHAPTER II   
LITERATURE REVIEW 
 
Overview of coagulase-positive Staphylococcus spp. 
Staphylococcus spp. are Gram-positive coccoid bacteria that can be broadly categorized 
into coagulase-positive and negative groups. The eight known coagulase positive 
Staphylococcus species include: S. aureus, S. schleiferi subsp. coagulans, S. hyicus, S. 
agnetis, S. lutrae, and the S. intermedius group (SIG) [1,2]. Of these, S. aureus and SIG 
are the most frequently encountered in dogs and horses [1]. Staphylococcus aureus is an 
important cause of opportunistic bacterial infections in humans and animals within 
hospital settings and the community at large, with antimicrobial drug-resistant strains 
representing a significant public health hazard [3]. The SIG species are highly related to 
each other and comprise four separate entities:  S. intermedius, S. pseudintermedius, and 
S. delphini groups A and B [2]. All of the SIG species were once classified as S. 
intermedius, which was discovered in 1976 and was often isolated from pigeons, dogs, 
mink, and horses as part of the native skin microbiota or as a cause of infections in dogs 
and cats [4,5]. Staphylococcus intermedius as currently defined is most frequently isolated 
from pigeons, and S. delphini has been isolated from the normal skin microbiota of 
dolphins, pigeons, mink, and horses [1]. Staphylococcus pseudintermedius was 
determined to be a species unique from S. intermedius in 2005 and is a frequent colonizer 
of healthy and diseased canine skin [2]. Staphylococcus pseudintermedius is the most 
common cause of pyoderma in dogs, with sporadic infections also reported in 
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immunocompromised people [6]. Members of the SIG can be difficult to tell apart from 
each other and S. aureus based on morphology and standard laboratory biochemical 
techniques alone, which can lead to misdiagnosis of human and animal S. 
pseudintermedius infections [7]. This review will focus primarily on S. aureus and S. 
pseudintermedius, the toxin genes they carry, and how they relate to infection in humans, 
dogs, and horses. 
 
Staphylococcal infections and the rise of methicillin resistance 
Methicillin resistance in staphylococci 
Methicillin-resistant S. aureus (MRSA) and S. pseudintermedius (MRSP) 
infections are common in humans and animals [8,9]. Methicillin was the first 
penicillinase-resistant  β-lactam antibiotic designed to combat staphylococcal infections 
and worked by inhibiting cross-linkage between peptidoglycans in the bacterial cell wall 
[10]. Methicillin is no longer used in clinical practice due to widespread resistance that 
was first noted in 1961, a year after its introduction [10]. Resistance to β-lactam antibiotics 
can be horizontally transferred between staphylococci through acquisition of the blaZ gene 
encoding a β-lactamase that imparts resistance to penicillin or the mecA cassette, which 
encodes an altered penicillin binding protein (penicillin binding protein 2a) that has a low 
affinity for all β-lactam antibiotics and imparts resistance to methicillin [11]. Methicillin 
was eventually supplanted by more effective and less toxic antimicrobials, but mecA-
mediated β-lactam resistance is still classified as “methicillin”-resistance as an indicator 
for resistance to all β-lactam drugs. The mecA gene is carried on a horizontally 
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transferrable, MGE called the staphylococcal cassette chromosome mec (SCCmec) and 
can be transferred between coagulase-negative and -positive species of staphylococci [12].  
 
Human infections 
Staphylococcus aureus is a major cause of soft tissue infections and bacteremia in 
people, and is the leading cause of infective endocarditis [13]. An estimated 72,444 people 
in the US developed MRSA invasive infections in 2014 [3]. Invasive infections  usually 
occur in tissues that are normally sterile, such as blood, bone, or urine [3]; and the rates of 
staphylococcal bacteremia have increased during the late 20th century. For instance, the 
yearly incidence of MRSA bacteremia in Canada increased from 0 cases per 100,000 
people in 1991 to 7.4 per 100,000 in 2005 [14]. Clinical MRSA infections result in 11,285 
deaths annually and cost $478 million to $2.2 billion in direct health care costs [3]. 
Staphylococcus aureus-associated cellulitis most commonly involves the feet and legs, but 
may also involve the hands, arms, torso, and face, and the histopathologic hallmark is 
subcutaneous abscessation [8]. Staphylococcus aureus causes a contagious localized 
dermatitis (bullous impetigo) in young children and a fatal, generalized blistering skin 
condition (staphylococcal scalded skin syndrome; SSSS) in infants [15,16]. Severe S. 
aureus skin infections can progress to necrotizing fasciitis in patients with a history of 
injectable drug use or secondary, immunomodulating clinical conditions, such as diabetes 
mellitus or hepatitis C [8]. 
Staphylococcus pseudintermedius is most frequently associated with skin/soft 
tissue infections and animal bite wounds in people, with rarer cases of bacteremia reported 
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[6,17,18]. Staphylococcus pseudintermedius can also colonize the nasal passages of 
people for prolonged periods, with veterinarians having higher colonization prevalence 
with MRSP than the general population [19,20], but colonization is often transient [21]. 
Once thought to be uncommon except in cases of dog bite, the prevalence of S. 
pseudintermedius infections in humans is difficult to determine due to frequent 
misidentification of S. pseudintermedius as S. aureus by commercial bacterial 
identification systems designed for humans [6]. Staphylococcus pseudintermedius 
infections in humans may often be misdiagnosed as S. aureus due to similarities in 
morphology and biochemical characteristics between the species, with one report 
describing a 13% (13/101) misdiagnosis rate [18]. Misdiagnoses of S. pseudintermedius 
infections in people are serious because there are differences in antimicrobial drug 
breakpoints between S. pseudintermedius and S. aureus which can lead to treatment failure 
due to MRSP being misidentified as methicillin-sensitive S. aureus [22].  
 
Canine infections  
While S. aureus infections do occur in dogs, S. pseudintermedius is the most 
common cause of pyoderma in dogs and is an important cause of post-surgical infections 
[23]. Staphylococcus pseudintermedius is also frequently cultured from the nares, 
pharynx, and perineal skin of asymptomatic, dermatologically healthy dogs [19,20]. 
Staphylococcus pseudintermedius can also carry SCCmec and can potentially transfer 
methicillin resistance to other S. pseudintermedius or S. aureus isolates [24]. The 
prevalence of methicillin-resistant Staphylococcus spp. colonization in healthy dogs varies 
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widely amongst regions, ranging from 6.5 - 73% [25,26], and the prevalence of MRSP 
and MRSA in healthy canine patients from referral hospital settings is reported to be 
between 0 - 6.2% and 0.5 - 1%, respectively [26-28]. Skin lesions attributable to S. 
pseudintermedius are often found on the ventral aspects of the abdomen and trunk, groin, 
muzzle, interdigital regions, and axilla [28]. Pyoderma usually presents in two forms, 
either as erythema of the skin with crusting papules or vesicles (superficial) or as alopecic 
nodules with extensive inflammation, draining tracts and surface ulceration (deep) [29]. 
As in humans, many dogs also have secondary clinical conditions that may predispose 
them to staphylococcal infections, such as autoimmune conditions, endocrinopathies, 
ectoparasitism, and paraneoplastic syndromes [30]. 
 
Equine infections 
The prevalence of S. aureus colonization in horses that live on farms ranges from 
1 to 8% in Canada [31] and between 4 and 39% in Europe [5,32]; and colonization 
prevalence rate in hospitalized horses was reported as 40-50% [32,33]. The nares of horses 
and other equids, as well as the carpal skin in hospitalized horses [33], are frequently 
colonized by methicillin sensitive S. aureus (MSSA). The prevalence of MRSA in healthy 
horses ranges from 0 to 6% [31,34], with most studies reporting a 4-5% prevalence [12,35-
40]. While many horses colonized with S. aureus are asymptomatic carriers, MSSA and 
MRSA infections have been associated with significant morbidity and mortality in horses 
[39], and MRSA can be transferred between humans and horses and amongst groups of 
horses [41,42] resulting in important public health implications. Soft tissue, skin, surgical 
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incision, and joint infections are the most common manifestations of MRSA infection in 
hospitalized horses [43]. In one survey of bacterial infections in horses from Canada, S. 
aureus was more frequently cultured from cases with severe, chronic pleuropneumonia 
than other sites in the respiratory tract, such as the nares or guttural pouches, and S. aureus 
was more often cultured from post-surgical infections than traumatic wounds [44]. Risk 
factors for horses developing MRSA infections in veterinary hospital or community 
settings include administration of ceftiofur, aminoglycosides or other antimicrobials 
within the prior 30 days, and previous MRSA colonization of the patient or horses housed 
nearby [12,45]. 
 
Staphylococcus spp. strain typing schemes and their importance in epidemiology 
S. aureus strains can be grouped into healthcare-associated (HA-MRSA) and 
community-acquired (CA-MRSA) based on the population in which the strain was first 
identified [46], but this designation can change over time. Genetic lineages of S. aureus 
and S. pseudintermedius can be grouped and categorized using several different typing 
schemes. MRSA and MRSP strains are grouped based on presence of specific components 
within the SCCmec cassette (Types I –XI) and differences in the direct repeat unit (dru) 
of the SCCmec cassette [47-49]. Both MS and MR S. aureus and S. pseudintermedius 
isolates can be typed based on similarities in the tandem repeat area of the staphylococcal 
protein A (spa) gene or within seven conserved genes in a technique called multi locus 
sequence typing (MLST) [50,51]. Interrelated S. aureus strains derived from a common 
ancestor can be further grouped into clonal complexes (CC), and some genetic lineages of 
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S. pseudintermedius have been grouped into CC [9,52]. An additional staphylococcal 
typing technique based on comparison of banding patterns generated via restriction 
enzyme digestion, pulsed-field gel electrophoresis (PFGE), was used to categorize strains 
before the development of the sequence-based methods mentioned above. Major strains 
were designated with the country of isolation and a number (i.e. USA 300) [53]. While 
PFGE is sensitive in determining similar and divergent strains, the technique is difficult 
to perform on large culture collections and it is harder to compare the results from different 
laboratories without obtaining reference strains [51], resulting in it gradually being 
supplanted by sequence-based typing methods for analysis of S. aureus strains.  
 
SCCmec typing 
The SCCmec is a MGE that can be transferred between staphylococci of the same 
or differing species [54]. The SCCmec integrates into the genome at a specific insertion 
sequence (ISS) within a 23S rRNA methyltransferase called orfX. As of 2017, there are 
eleven SCCmec types curated by the International Working Group on the Classification 
of Staphylococcal Cassette Chromosome Elements (IWG-SCC) [55]. The basic 
components of SCCmec types I – X are the insertion sequence (IS431), mecA encoding 
the alternate penicillin binding protein 2a, a complete or truncated version of the mecA 
regulatory gene (mecR1), and cassette recombinase complexes (ccr, of which there are 
three genes and four allotypes) that are flanked by direct repeat sequences containing the 
ISS [54]. Some of the types also carry transposons (such as Tn4001, Tn554, or ψTn554) 
or resistance determinants to heavy metals, such as arsenic, cadmium, and copper. The 
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presence or absence of these genes or differences in component type/ arrangement 
determines the SCCmec type, and a series of multiplex conventional PCRs were developed 
to detect types I – VI [47]. Type XI SCCmec encodes the divergent mec gene, mecC (also 
known as the mecALGA251 homologue), that was recently discovered in bovine MRSA 
strains [56]. One study in the early 2000s found that CA-MRSA strains from the central 
US were more likely to carry SCCmec type IV when compared to HA-MRSA [46].  
S. pseudintermedius MR isolates carry type II, IV, or V SCCmec but can also carry 
a hybrid type II-III SCCmec that contains elements of Staphylococcus epidermidis 
SCCmec type II and S. aureus SCCmec type III [57]. SCCmec type VII, also called VII-
241, was discovered in a MRSP isolate from Switzerland [57]. Strains of MRSP prevalent 
in Israel carry a pseudo-SCCmec, ψSCCmec57395, which carries mecA and heavy metal 
resistance determinants but lacks ccr genes [58]; one MRSP isolate cultured from a dog 
in Thailand carried a novel SCCmec composite island called SCCmecAI16-SCCczrAI16-CI 
that encodes restriction modification and heavy metal resistance genes [59].  
 
Spa and dru typing 
Two single gene typing schemes currently in use for staphylococci are based on 
identifying variable-number tandem repeat (VNTR) sequences in specific regions (X- 
regions) of the staphylococcal protein A (spa) gene and SCCmec direct repeat unit (dru) 
region. The spa typing schemes can be used for both MR and MS S. aureus and S. 
pseudintermedius, and dru typing is used for MR staphylococci [48-50,60,61]. The spa 
gene encodes an IgG binding protein and is carried as a single copy in S. aureus but can 
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occur as two orthologues carried in succession in S. pseudintermedius (also designated as 
spsP and spsQ) [62], with spsQ containing the X-region that determines spa type in this 
species. The PCR primers originally developed to amplify spa [50] in S. pseudintermedius 
often do not bind specifically to the correct spa gene, resulting in a high proportion of 
isolates that could not be spa typed due to non-specific amplification of products; this 
anomaly was corrected with primer redesign in a later study which increased the number 
of spa-typable isolates [9]. The spa typing naming schemes for S. aureus and S. 
pseudintermedius are not interchangeable and are curated by different groups (S. aureus- 
Ridom SpaServer, http://spa.ridom.de/spatypes.shtml; S. pseudintermedius- Arshnee 
Moodley). Dru typing is based on a similar method of identifying 40 bp-long VNTR 
sequences in the direct-repeat unit region of SCCmec adjacent to IS431 in S. aureus and 
S. pseudintermedius [48,61]. The online dru typing database (http://dru-typing.org/site/) 
is currently curated by Richard V. Goering. As of October 2017, there are 17,278 spa types 
for S. aureus, 81 spa types for S. pseudintermedius, and 530 dru types for MRSA and 
MRSP. 
 
Multi locus sequence typing (MLST) and ribosomal MLST (rMLST) 
The multi locus sequence typing (MLST) method is based on determining allelic 
variation in highly conserved genes with specific combinations of gene allele types 
determining overall sequence type (ST). The S. aureus MLST is based on allelic variation 
in seven conserved genes: carbamate kinase (arcC), shikimate dehydrogenase (aroE), 
glycerol kinase (glp), guanylate kinase (gmk), phosphate acetyltransferase (pta), 
 12 
 
triosephosphate isomerase (tpi), and acetyl coenzyme A acetyltransferase (yqiL) [51,63]. 
Founding STs of CC are determined by identifying STs that have the greatest number of 
single-locus variants (i.e. isolates that differed from the most STs at only a single locus). 
The major CC associated with human disease worldwide are USA100 (CC5), USA200 
(CC30), USA300 (CC8), USA400 (CC1), and USA600 (CC45) [53]. In the US, CC5 
strains are associated with nasal colonization and invasive infections [64], while CC30 is 
associated with mucosal infections and toxic shock syndrome in women [65]; CC1 is the 
predominant group in Canada and most isolates are spa type t127 [66]. Most epidemic 
CA-MRSA infections in the US are caused by CC8, and these strains are often carry 
multiple cytolytic toxin genes [53,67]. In European horses, the most prevalent MRSA 
strains are ST398, 8, and 612 [34]. In Canada, ST8-SCCmec type IV MRSA strains have 
also been described in veterinary hospital-associated outbreaks [43]. While the first reports 
of MRSA in horses came from the US [68] in the 1990s and a few subsequent reports 
[69,70] have characterized MRSA from horses in the US utilizing current sequence-based 
typing methods, none of the US or Canadian studies have included MSSA derived from 
horses with infections. 
Since the 2010s, MLST schemes have been developed for S. pseudintermedius that 
have allowed more precise characterization of isolates into ST and grouping of a few 
genetic lineages into CC [52,71]. The S. pseudintermedius MLST is based on allelic 
variation in seven conserved genes: elongation factor Tu (tuf), 60 kDa chaperonin (cpn60), 
phosphate acetyltransferase (pta), adenylosuccinate synthetase (purA), formate 
dehydrogenase (fdh), sodium sulfate symporter (sar), and acetate kinase (ack) [71]. To 
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date, only a few S. pseudintermedius isolates derived from human infections have been 
characterized by MLST [18,71-73]. The most common ST in a recent survey that included 
canine-derived isolates collected from all geographical regions of the US were 68, 71, and 
84, with each of these ST being founders of CC that encompassed dozens of other ST [52]. 
Most of the MRSP isolated are descended from a few clones, while methicillin-sensitive 
S. pseudintermedius (MSSP) isolates do not spread clonally and have diverse ST [18,52]. 
ST71 is frequently associated with SCCmec type II-III [57] and is a unique ST because it 
includes both MRSP and MSSP lineages, whereas other groups, such as ST68 and 84, are 
composed of MRSP [52]; this finding suggests that there may be ready transfer of 
antibiotic resistance genes between MRSP and MSSP members of this lineage. In one 
case, a human-derived MRSP ST71 strain also demonstrated a reversible small colony 
variant phenotype similar to S. aureus that imparted resistance to multiple antimicrobials 
[72]. ST71 and ST68 MRSP have also been frequently associated with epidemic outbreaks 
in veterinary hospitals in Europe and the US, respectively [74]. Methicillin-resistant ST71 
strains have been associated with nasal infection and colonization of 
immunocompromised patients [72,73] with and without ownership of pets. The ST71 
MRSP lineage is also the only type documented to be associated with an outbreak of 
blistering skin lesions in diabetic human hospital patients, the majority without 
demonstrated contact with dogs [75]. 
For determining ribosomal MLST (rMLST) in staphylococci, the allelic variation 
in 51 non-paralogous ribosomal genes is compared to assign type. The 53-gene rMLST 
scheme can be used to type any genus/species of bacteria, but as most staphylococci have 
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two copies of the rpsN and rpmG genes, these genes are excluded from the typing scheme 
for staphylococci [76,77]. Differences in the alleles for any one of the genes constitutes a 
new rMLST. Of the typing methods discussed in this review, rMLST is the newest method 
and the one with the least published data because the technique is not PCR based and was 
developed for isolates that have been subjected to whole genome sequencing (WGS). As 
of October 2017, there are over 4,500 rMLST of  S. aureus deposited in the rMLST 
database on the online Bacterial Isolate Genome Sequence Database (BIGSdb) genomics 
platform (https://pubmlst.org/rmlst/; curator- Keith Jolley) [78]. In contrast, there are only 
23 rMLST reported for S. pseudintermedius in the database. Some of the most common 
rMLST for livestock-associated S. aureus strains from Europe based on querying the 
BIGSdb are: 4290 (ST1), 4340 (ST398), and 4499 (ST133); while common MRSA 
rMLST are 4326 (ST5) and 4320 (ST8). The predominant S. pseudintermedius rMLST are 
17490 (ST71), 17491 (ST68), and 48490 (ST84) based on BIGSdb data. 
 
Classes of staphylococcal toxins 
Staphylococcal toxins are divided into three general classes: exfoliative, 
membrane damaging toxins, and superantigens (SAgs). Carriage of specific toxin genes is 
prevalent within certain genetic lineages of S. aureus, and most isolates carry multiple 
SAgs and other toxin genes. Toxin genes can be horizontally transferred between 
staphylococci and are often carried on large MGE called pathogenicity islands (PI), 
bacteriophages that integrate into the bacterial genome as prophages, or plasmids [79]. 
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Exfoliative toxins 
Exfoliative toxins (ET) are potent serine proteases that are secreted by 
staphylococci and are thought to facilitate infection through cleavage of the keratinocyte 
junctional protein desmoglein-1 (Dsg1) in the stratum granulosum, resulting in extensive 
blistering and separation of the superficial layers of the epidermis and sparing of the basal 
layers [80]. In S. aureus, the four recognized ET are ETA, ETB, ETC, and ETD, with ETA 
and ETB being the most associated with disease [81-83]. Staphylococcus aureus strains 
responsible for bullous impetigo and SSSS in children and infants often carry ETA and 
ETB [15,16]. Carriage of eta and etb has also been documented in S. aureus strains 
isolated from wounds, implant, and urinary tract infections [84-87], with the eta gene 
being more prevalent in isolates from North America and Europe and etb being more 
prevalent in isolates from Japan [83]. ETC has only been described in one isolate that was 
collected in the 1990s from a horse with dermatitis [81]. However, the DNA sequence 
encoding ETC and other structural properties of the protein have not been reported, and 
the ETC carrying reference strain (Horse-1) has never been sequenced or banked in a 
commercial repository for study. ETD was identified in 2002 in S. aureus N315 and is 
encoded on a 9,054 bp PI [82]. ETD has been isolated from samples collected from adults 
with furunculosis and skin abscesses, and while it does cleave Dsg1 experimentally, its 
overall significance in S. aureus pathogenesis is unknown [82,86]. In young pigs, SHETA 
and SHETB expression in S. hyicus is associated with exudative epidermitis, which results 
in epidermal blistering similar to SSSS [83]. The four proposed ET genes in S. 
pseudintermedius are speta, siet, expA (formerly known as exi), and expB [88,89]. The 
 16 
 
potential for horizontal transfer of the S. pseudintermedius ET genes has not been 
investigated, and it is unknown if the genes are carried on MGE. While studies with 
recombinant EXPA and EXPB have demonstrated that they target canine Dsg1, the protein 
crystal structures of the S. pseudintermedius ET have not been evaluated.  
 
Membrane damaging toxins 
Pore-forming toxins 
The main function of pore-forming toxins is to damage the cellular membrane of 
the host cell, which can cause cellular lysis and necrosis of tissues. Pore-forming toxins 
produced by staphylococci include: α-hemolysin (Hla), leukocidins, and phenol-soluble 
modulins [90]. Approximately 95% of all S. aureus produce Hla, which is responsible for 
lysis of a wide variety of cell types, including erythrocytes, mononuclear leukocytes, and 
epithelial cells [90]. Hla was one of the first identified S. aureus toxins and causes 
hemolysis of erythrocytes through binding of surface a disintegrin and metalloprotease 10 
(ADAM10) receptors. While highly cytolytic to rabbit erythrocytes, Hla does not cause 
hemolysis of human erythrocytes due to ADAM10 expression differences on the surface 
of erythrocytes between the two species [44]. 
The leukocidins have been associated with recurrent soft tissue infections and 
necrotizing pneumonia in people [90]. Leucocidins contribute to immune system evasion 
through lysis of neutrophils, monocytes and macrophages. Leucocidins are composed of 
two class S and F protein subunits that oligomerize to form a β-barreled pore, and the 
degree of cellular lysis induced by each leucocidin differs amongst host species [90,91]. 
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The leucocidins of importance to human and livestock infections are γ-hemolysin, 
leucocidin AB (LukAB), leucocidin ED (LukED), Panton-Valentine leucocidin (LukSF-
PVL), leucocidin PQ (LukPQ), and leucocidin MF’ (LukMF’). Gamma-hemolysin is 
formed by interaction of the HlgAB and HlgCB components, which bind to phagocyte 
chemokine (CXCR1, CXCR2 and CCR2) and complement (C5aR and C5L2) receptors, 
respectively, for targeted killing of monocytes and neutrophils [92]. LukAB (also known 
as LukGH) kills human neutrophils by binding to the Mac1 integrin and is carried by most 
isolates [93,94]. LukED has broad targeting action with different chemokine receptors and 
can kill neutrophils, T-lymphocytes, macrophages, and dendritic cells, effectively 
disarming both the host’s innate and adaptive immune responses [95]. LukED and γ-
hemolysin carriage are ubiquitous in S. aureus, with approximately 90-100% of isolates 
carrying both genes [16,96]. 
 LukSF-PVL is highly toxic to human and rabbit neutrophils, and PVL carrying 
strains have been associated with necrotizing pneumonia in murine models of human 
infection [97]. LukPQ has been implicated as a cause of pneumonia, and LukMF’ is often 
secreted in bovine mastitis cases [91,98]. The newly categorized LukPQ and LukMF’ 
specifically target equine and ruminant neutrophils, respectively [91,98]. LukPQ-positive 
isolates have only been described in isolates collected from horses in Europe, and LukPQ 
was not present in a small collection of S. aureus isolates collected from horses in Ohio 
[91]. Leucocidins are encoded on bacteriophages that integrate into the bacterial host’s 
genome (prophages) with PVL encoded on Φ-PVL, LukPQ on ΦSaeq1 (deposited as the 
strain 3711 prophage), and LukMF’ on Φ Sa1 [91]. A similar two component leucocidin, 
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LukS-I and LukF-I, has been identified in S. intermedius isolates from pigeons and S. 
pseudintermedius isolates from dogs, but the significance is unknown [99].  
Phenol-soluble modulins (also known as δ- hemolysins) are peptides with cytolytic 
and pro-inflammatory properties that are ubiquitously carried in S. aureus and may have 
a role in initial colonization of the host through formation of biofilms [90]. BacSp222 is a 
peptide produced by S. pseudintermedius that lyses other Gram-positive bacteria and has 
characteristics of a bacteriocin [100]. 
 
Beta-hemolysin  
Beta-hemolysin (hlb) does not form pores in the cell membrane and is a 
sphingomyelinase that hydrolyzes the lipid sphingomyelin in the plasma membrane of 
host cells, which results in a conversion of sphingomyelin into ceramide and 
phosphorylcholine. The specific action of β-hemolysin that causes cell death is not known, 
but it is thought to alter cell membrane fluidity and disrupt cellular signaling by causing 
cholesterol to aggregate in the lipid bilayer [101]. Beta-hemolysin carriage is common, 
with approximately 70% of equid S. aureus isolates carrying hlb in one report [96]. 
 
Superantigens 
The staphylococcal SAgs cause mass, indiscriminate stimulation of T- 
lymphocytes through bridging of the variable β-chains with α or other β-chains of major 
histocompatibility complex (MHC) class II molecules without the need for antigen 
presentation. The resulting cytokine release by T-lymphocytes and other antigen 
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presenting cells can cause potential shock and organ failure in the host. Most S. aureus 
strains carry 5-6 SAgs genes [90]. The S. aureus SAgs include toxic shock syndrome toxin 
(TSST-1 or SEF), enterotoxins A-E, G-J, and R-T, and the enterotoxin-like (SEl) agents 
K-Q, U, V, and X [90]. Secretion of TSST-1 into the blood induces fever and blood 
pressure changes within the host, and TSST-1 was first associated with shock in 
menstruating women with a history of usage of high absorbency tampons [102]. In 
animals, TSST-1 carriage has frequently been reported in isolates cultured from goats, and 
TSST-1 expression has been associated with a toxic shock-like syndrome in a horse with 
pneumonia [102,103]. Enterotoxins are associated with staphylococcal food poisoning and 
induce vomiting in primates [90]. Carriage of SEA and SEC is common in USA200 and 
USA400 strains, while carriage of enterotoxins in the PVL-positive USA300 strains is 
uncommon [53]. Enterotoxin H carriage is predominately associated with CC1 lineage, 
while ser and sej carriage is associated with CC5 MRSA [104]. Enterotoxins D and R are 
often carried separately or together on plasmids [105]. 
Experimentally, the SEl toxins have similar properties to enterotoxins, but have 
not been proven to induce vomiting in humans or primate models [90]. Most of the SEl 
proteins have not been extensively studied, but expression of SEl-X is associated with 
necrotizing pneumonia in people with MRSA and development of diabetic foot ulcers 
[106,107]. The enterotoxin genes seg and sei, and SEl genes sel-m, sel-n and sel-o are 
encoded on a PI in a grouping called the enterotoxin gene cluster (egc1) [108] or if 
containing sel-u or variant sel-u, egc2 or egc3, respectively. The egc is commonly 
encountered in CC5 or CC30 MRSA [104]. Most enterotoxins and SEl are encoded on 
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MGE carried by bacteriophages, PIs, or plasmids, and carriage is variable among isolates, 
with an exception being SEl-X which is encoded on the core genome and occurs in 
approximately 90% of S. aureus isolates [106,107]. Carriage of SEl-K, SEl-Q, and SEl-X 
is commonly encountered in USA300 strains [53]. Carriage of SEl toxins has not been 
evaluated in S. aureus isolates from horses. In S. pseudintermedius, the seccanine and se-int 
genes have been identified as possible enterotoxins, but their importance in clinical disease 
is unknown [109,110]. Analogs to the S. aureus TSST-1, SEA, SEB, SEC, and SED 
enterotoxins have been detected via PCR in S. pseudintermedius isolates from dogs with 
and without pyoderma [111,112], but whether the PCR amplicons represented the targeted 
S. aureus SAg genes has not been determined as DNA sequencing of the amplicons was 
not done to determine if the PCR primers were specific to the enterotoxin genes 
investigated. 
 
Relationships between toxin gene carriage, strain type, and antibiotic resistance 
The secretion of exoproteins, including toxins, in staphylococci is controlled by 
the accessory gene regulator (agr) locus. The agrD gene encodes a precursor for a peptide 
(autoinducing peptide; AIP), of which there are four different types, that is used in quorum 
sensing between staphylococci and is capable of cross inhibiting gene expression 
pathways in staphylococci producing a different type of AIP [80,113]. The agr type is 
closely linked to the genetic lineage of a strain, determined through the strain typing 
methods, and certain agr types have been associated with specific types of infection in 
people. The methods for determining agr type in S. aureus and S. pseudintermedius are 
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different and are not interchangeable [113,114]. Exfoliative toxin producing strains of S. 
aureus are often associated with type IV agr systems [80], while bullous impetigo is 
associated with type I and endocarditis is more associated with types I and II [113]. While 
a definitive link between type of infection and agr system has not been demonstrated in S. 
pseudintermedius, agr type III is commonly observed in the predominant European MRSP 
strain ST71 [115]. 
Methicillin resistance in S. aureus and S. pseudintermedius spreads clonally, with 
a few predominant, interrelated strains spreading through a human or animal population 
or geographic area due to antimicrobial selection pressures, with MRSA strains often 
concurrently carrying leucocidin genes, ET, or other virulence factors [9,16]. Carriage of 
toxin genes often coincides with antimicrobial resistance, carriage of other virulence 
genes, or strain type in S. aureus. For instance, the predominant MRSA strain in North 
America is USA 300, which is a PVL carrying SCCmec type IV strain that rose to 
prominence in 2011 [116]. Methicillin-resistant S. aureus ST8 and SCCmec type IV 
isolates frequently carry a virulence element, the arginine catabolic mobile element 
(ACME), which enhances the ability of carrying strains to colonize human skin [117], but 
this element is not prevalent in livestock associated strains of MRSA [118]. The S. aureus 
phenol soluble modulin gene, psm, is located predominately on SCCmec II, III, and VIII, 
and is transferred at the same time as methicillin resistance genes between isolates [119]. 
In European horses, one of the most prevalent S. aureus strains, ST398 [120], frequently 
carries the prophage that encodes lukPQ [91]. Carriage of lukPQ is also associated with 
other CC typically associated with livestock, such as CC1, CC133, and CC1660 [91]. The 
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plasmid that encodes etb in S. aureus also carries a cadmium resistance operon and an 
epidermal cell differentiation inhibitor (EDIN) called ADP-ribosyltransferase (edinC), a 
Rho GTPase-inactivating protein, which interferes with actin cytoskeleton regulation in 
bacteria. Strains that carry the etb plasmid are also more likely to carry edinB on the 
chromosome, a gene that is involved in the development of bacteremia in pneumonia 
patients with community acquired MRSA [121,122]. Staphylococcus aureus strains that 
carry etb are more likely to be methicillin sensitive [123], whereas eta carrying isolates 
often have strong clonal associations and are frequently methicillin-resistant [15,16]. 
While S. aureus virulence factors have been studied for many years, it is unknown if 
carriage of toxin genes or other virulence factors coincides with particular strains or 
genetic lineages in S. pseudintermedius. 
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CHAPTER III 
S. PSEUDINTERMEDIUS EXFOLIATIVE TOXIN GENE CARRIAGE IN ISOLATES 
FROM DOGS (2007–2013) 
 
Introduction 
The four proposed ET genes in S. pseudintermedius are speta, siet, expA (formerly 
known as exi), and expB [88,89,124,125]. Previous studies that have included isolates 
from healthy and diseased dogs have reported prevalence rates of 0 - 23% for expA and 2 
- 28% for expB, but the sample sizes were relatively small [112,115,126-130]. In contrast, 
carriage of the speta and siet genes has been highly prevalent in previous studies, with 
almost universal carriage in the examined isolates [115,131]. The purpose of this study 
was to determine the prevalence of ET gene carriage in S. pseudintermedius isolates 
cultured from dogs with pyoderma, other clinical conditions, and dermatologically healthy 
dogs in a referral hospital population. We hypothesized that there would be differences in 
ET gene carriage between healthy and diseased dogs and that ET gene carriage would 
differ based on patient demographics, type of infection, methicillin-resistance status 
and/or genetic lineage of the isolate. 
Using a subset of the dogs in the prevalence study that also had skin biopsies 
collected within the same time frame as the bacterial culture, we evaluated the severity, 
type, and depth of inflammation in hematoxylin and eosin (H&E) stained, FFPE skin 
biopsies. The purpose of this analysis was to evaluate if there was a difference in 
inflammation severity and/or type of inflammation between dogs in the prevalence study. 
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We hypothesized that there would be differences between inflammation severity, type of 
inflammation, and depth of inflammation in skin biopsies collected from dogs that 
cultured S. pseudintermedius isolates of differing ET carriage profiles; we expected that 
the speta+siet+expA and the speta+siet+expB profiles would be associated with more 
severe inflammation in the paired biopsies. 
 
Materials and methods 
Strain collection and demographics  
  All S. pseudintermedius isolates used in this study were part of an institutional 
veterinary clinical strain collection composed of 500 isolates collected from dogs that 
presented to the Texas A&M University Veterinary Medical Teaching Hospital from 
2007-2013. The 500 isolates were collected from 475 individual dogs. Within this 
population, there were 359 isolates (72%) that were residual patient diagnostic samples 
collected from dogs with various clinical conditions, of which pyoderma (n = 99), surgical 
site infections (n = 38), and urinary tract infections (n = 59) represented the most frequent 
culture sites. The database also included 141 isolates (28%) collected as part of a 
staphylococcal screening study that cultured the nares and perineal skin of 
dermatologically healthy dogs that presented for orthopedic surgery evaluation. Sampling 
conformed to the ethical guidelines and standards of care for the hospital, and the animal 
use protocol for the collection of samples from the healthy dog group was approved by 
the institutional animal care and use committee (AUP 2010-068).  
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The mean age of dogs from which isolates were derived was 6.3 years (SD = 3.65 
years; median = 6 years; range, 2 months to 16 years). There were 238 isolates from spayed 
females, 24 isolates from intact females, 181 isolates from castrated males, and 57 isolates 
from intact males. Eighty-eight breeds were represented and there were 57 mixed-breed 
dogs. The majority of the isolates came from dogs that were classified into the AKC 
Sporting (n = 127; 25%) and Toy (n = 70; 14%) groups. Labrador retriever (n = 76; 16%) 
was the most frequent breed encountered in the diseased and healthy groups. 
Isolates were identified as S. pseudintermedius at the time of initial diagnosis or 
screening using a combination of standard laboratory techniques, such as evaluation for 
coagulase and urease production, the ability to grow in the presence of 6.5% sodium 
chloride, and the ability to ferment trehalose and mannitol, and confirmation with a 
diagnostic staphylococcal speciation PCR using previously described methods [1,132]. 
Antimicrobial resistance was determined at the time of initial culture through minimum 
inhibitory concentration testing, and methicillin resistance was determined via mecA PCR, 
and oxacillin and cefoxitin disk diffusion as previously described [22]. Isolates were 
preserved in lysogeny broth with 20% glycerol and frozen at -80ºC until DNA extraction 
was performed. 
 
DNA extraction and molecular techniques 
Isolates were struck onto Mueller-Hinton agar with a 96-pin replicator and 
incubated at 37°C overnight. A single colony was inoculated into 1 mL of lysogeny broth 
in 96-well format and incubated at 37°C overnight for DNA extraction. Genomic DNA 
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was extracted from the samples using a Wizard® SV 96 Genomic DNA Purification 
System (Promega Corporation, Madison, WI, USA) as per the manufacturer’s 
instructions, except an enzymatic lysis buffer composed of 50mM EDTA and 40 mg/mL 
lysozyme was used in place of the included kit lysis buffer and samples were incubated at 
37°C for 2 h with lysis buffer before vacuum extraction. The PCR primers used for each 
of the ET genes are listed in Table 1.  
 
 
 
 
Table 1: PCR primers for amplification of ET genes. The underlined regions indicate 
insertion of SphI (GCATGC), BamHI (GGATCC) and HindIII (AAGCTT) restriction 
enzyme cut site sequences in the original siet and expA primers [88]. 
 
 
 
PCR reactions consisted of 1 x Buffer (20 mM Mg2), 2.5 mM each DNTP, 0.2 μM 
each primer, 1.25 U of Takara Ex Taq™ (Takara Bio, Inc., Kyoto, Japan), and 25-100 ng 
template per 50 µl sample. PCR thermocycler conditions for the ET genes consisted of an 
initial denaturing step at 94°C for 5 min; 30 cycles of denaturation at 94°C for 1 min, 
Gene Forward primer (5’ → 
3’) 
Reverse primer (5’ → 
3’) 
Amplicon 
size (bp) 
Reference 
speta AAAAAGCGCCTTTAG
CAACA 
GTGAACACAGATG
CGACCAG 
201 This study 
siet GGATCCACAAGTACT
GTACTTGAAGAAGG 
AAGCTTCCCTTCA
TATTTGTACATTG
GTCGT 
875 [88] 
expA 
(exi) 
TAAGCATGCAATCAT
ATAATGAGGAAGAA
ATATTAAAAAAGCA
A 
TCTGGATCCTTCTT
CTTGTAATTTAGC
TCTTTTTTTCAAGT
CTTC 
755 [88] 
expB CGCCTGGCGTATATG
CTAAAAC 
TTCAGCGCCAAAT
TGTCCAT 
326 This study 
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annealing at either 55°C (expA, expB, or speta) or 60°C (siet) for 1 min, and extension at 
72°C for 1 min; and a final elongation step of 72°C for 7 min. SCCmec typing via 
multiplex PCR for ccr type I-VI and class A-C mec assignment was performed on all MR 
isolates as previously described [47]. PCR screening for the hybrid Staphylococcus 
epidermidis Type II and S. aureus Type III SCCmec elements (Type II-III) and for 
SCCmec Type VII-241 were also conducted as previously described [57]. All of the 
isolates from pyoderma and surgical site infections, all of the MR isolates in the healthy 
group, and a random selection of MS and MR isolates (n = 82) cultured from other body 
sites in the diseased group were spa typed using the original [50] and modified [9] primer 
sets and dru typed [48] as previously described. Amplicons were visualized via 
electrophoresis at 110 V on a 1% agarose gel stained with GelRed™ (Biotium, USA).  
Selected PCR reactions were purified with a NucleoSpin® Gel and PCR Clean-up 
Kit (Macherey-Nagel, Germany) as per the manufacturer’s instructions. As there were not 
any ET-specific S. pseudintermedius reference strains at the time of writing this 
manuscript, the specificity of each ET primer set was validated through sequencing. 
Respective amplicons targeting the speta, siet, expA, and expB genes, and the spa and dru 
repeat regions of select isolates were submitted for Sanger sequencing (Eton Biosciences, 
Inc., San Diego, CA, USA). The ET gene nucleotide sequences were queried against the 
NCBI reference database using the nucleotide Basic Local Alignment Search Tool 
(BLAST). The speta, siet, expA, and expB amplicons had 99% identity to their respective 
reference sequences in GenBank: NC_014925.1 (formerly ADX77621.1), AB099710.1, 
AB489850.1, and AB569087.1. Spa and dru types were assigned as described previously 
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based on tandem repeat comparison to the respective databases (spa curator- Dr. Arshnee 
Moodley and dru database- www.drutyping.org). 
 
Slide scoring systems 
The H&E stained, FFPE skin biopsies were examined for 25 of the dogs evaluated 
in the ET prevalence study. The skin biopsies were residual diagnostic specimens 
submitted by the attending clinician during the same time period as the bacterial cultures 
(i.e. paired biopsies), but did not necessary represent the exact region cultured. The slides 
for each of the cases were blinded by an individual that had not seen the ET carriage 
prevalence data and were read by a board certified veterinary anatomic pathologist (LKB). 
A grading scale was developed to subjectively score the severity of inflammation. Briefly, 
< 10 inflammatory cells per field was minimal (score 0); > 10 and ≤ 50 was mild (1); > 50 
and ≤ 300 was moderate (2); and > 300 was severe (3). Histologic representations of the 
severity score scale are given in Fig. 1. An individual score was given for each of ten 400x 
(40x objective and 10x ocular lens) fields within areas of inflammation on the slide, and 
the results from each field were averaged to produce an overall inflammation severity 
score for the slide. If more than one slide of a similar lesion was evaluated for a single 
case, the slide with the more severe inflammation score was used in the final analysis after 
un-blinding of the slides.  
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Inflammation type was divided into polymorphonuclear (neutrophils and 
eosinophils), mononuclear (encompassing lymphocytic, plasmacytic, and histiocytic 
inflammatory cells), and a combined mononuclear/ polymorphonuclear group. 
Assignment of type was based on which group represented > 60% of the inflammatory 
cells within the H&E section. If sections contained equal numbers of polymorphonuclear 
and mononuclear (1:1) inflammation, the type was classified as mononuclear/ 
polymorphonuclear. The depth of inflammation was classified as superficial if the 
majority was localized to the epidermis or superficial dermis or classified as deep if 
inflammation extended into the deep dermis or underlying panniculus, muscle or 
Figure 1: Inflammation scoring system examples. Representative 400x fields of 
each of the score categories in the H&E stained skin biopsies (Olympus DP74 
microscope camera; Tokyo, Japan). The scale bars represent 20 µm. 
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cartilaginous structures. The pathologist also noted if coccoid bacteria were visible in the 
H&E section. 
 
Statistical analyses 
All analyses for the prevalence study were performed using S-PLUS statistical 
software (Version 8.2, TIBCO, Seattle, WA). To assess for relationships between breed 
and ET gene carriage, the purebred dogs were categorized based on American Kennel 
Club Group (i.e. Sporting, Hound, Toy, etc.) [133]. For continuous variables (e.g., age), 
linear mixed-effects modeling was used when possible to account for some isolates being 
from the same dog.  For comparisons of toxin type (i.e. presence or absence of toxin gene 
carriage), random-effects logistic regression was used to account for the correlation of 
some dogs contributing multiple isolates.  When there were 0 values in some cells, 
random-effects logistic regression was not possible and organisms were considered 
without regard for correlation among observations from the same dog. These categorical 
variables were compared using chi-squared or Fisher’s exact test when expected cells had 
counts fewer than 5. A P value less than 0.05 was considered significant. All statistical 
analyses for the inflammation scoring study were done with JMP® Pro 12.2.0 (SAS 
Institute, Inc., Cary, NC). Categorical variables were also compared using Fisher’s exact 
test when expected cells had counts fewer than 5 or a two-tailed Fisher’s exact test. A P 
value less than 0.05 was considered significant in both studies. 
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Results and discussion 
Prevalence study 
ET gene carriage 
Of the 500 isolates, 100% (500/500), 99% (497/500), 13% (67/500), and 16% 
(80/500) were positive for the speta, siet, expA, and expB ET genes, respectively. The gene 
combinations (Fig. 2) observed were: speta alone (n = 3), speta+siet (n = 357), 
speta+siet+expA (n = 60), speta+siet+expB (n = 73), and speta+siet+expA+expB (n = 7). 
The expA and expB genes were always carried concurrently with siet. Because of the 
ubiquitous carriage of speta and siet, the statistical analyses focused on carriage of expA 
or expB.  
 
Figure 2: S. pseudintermedius ET carriage profiles observed in isolates from dogs. 
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There was no correlation between carriage of expA or expB by the isolate and sex 
of the associated dog (P = 0.34 and 0.064, respectively). The ages of dogs with isolates 
that were expA-positive or expB-positive did not differ (P = 0.9971 and P = 0.8767, 
respectively). The proportion of expA and expB positive isolates did not differ by 
American Kennel Club (AKC) group (P = 0.9875 and 0.5913, respectively). Although the 
proportion of expA-positive isolates was lower among those from diseased dogs (12%; 
43/359) than healthy dogs (17%; 24/141), this difference was not significant (P = 0.1790). 
The proportion of isolates from diseased dogs that were positive for expB (16%; 56/359) 
was also similar to that of isolates from healthy dogs (17%; 24/141).  
When considering both the healthy and diseased groups, the odds of pyoderma 
were 2.5 times greater for dogs that were expA-positive relative to dogs that were expA-
negative (95% CI, > 1.0 to 6.3; P = 0.0439). The odds of pyoderma were not significantly 
different for expB-positive healthy and diseased dogs (P = 0.1741). The odds of surgical 
site infection were also not significantly different for expA or expB-positive healthy and 
diseased dogs (P= 0.0582 and 0.1741, respectively).  
 
Antibiotic resistance 
Resistance to ampicillin and doxycycline was frequently encountered in the 
isolates, occurring in 78% (388/497) and 40% (133/331) of the isolates, respectively. 
Resistance to erythromycin (33%; 162/496), trimethoprim sulfonamide combination drugs 
(30%; 151/496), enrofloxacin (27%; 136/497), and gentamicin (24%; 117/496) was also 
prevalent, while chloramphenicol (14%; 70/497) and rifampin (4%; 13/331) resistance 
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was low. There were 159 methicillin-resistant (MR) S. pseudintermedius isolates; 147 in 
the diseased dog group and 12 in the healthy dog group. All of the speta+siet+expA+expB 
and speta only isolates were methicillin-sensitive (MS). Of the 99 isolates from dogs with 
pyoderma, 49 isolates were MR and 50 were MS.  The proportion of pyoderma isolates 
that were expA-positive was similar among those that were MR (18%; 9/49) and MS (20%; 
10/50) (P = 0.9609).  Using random-effects logistic regression to account for clustering 
among observations, the odds of dogs with MR isolates being expA-positive (1.2; 95% CI, 
0.2 to 8.1) were not significantly (P = 0.8190) greater than for MS isolates. Of the 38 
isolates from surgical site infections, 19 were MR and 19 were MS. As only one and three 
isolates were expA and expB-positive, respectively, odds ratios could not be computed.  
 
Typing characteristics 
SCCmec typing was performed on all MR isolates and yielded 65% (103/159) 
Type V, 16% (26/159) Type II-III, 7.5 % (12/159) Type IV, 1.8% (3/159) Type II, 0.6% 
(1/159) Type VII-241, and 8.8% (14/159) untypeable using the current conventional PCR 
typing schemes. Of the 144 isolates that could be SCCmec typed, 8% (11/144) were expA-
positive and 9% (14/144) were expB-positive. Spa type was successfully determined for 
52% (68/131) of the MR isolates tested. There were 22 distinct spa and 19 dru types. The 
most common spa types for the MR isolates were t06 (n = 43) and t02 (n = 11), and the 
most common dru types were dt11a (n = 29), dt11af (n = 21), and dt9a (n = 17). The most 
common SCCmec, spa, and dru type combinations were V+t06+dt11a (n = 20) and 
V+t06+dt11af (n = 11). Five new spa types were identified and added to the database: t77 
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(n = 2; r01-r02-r03-r03-r04-r05), t78 (n = 1; r01-r09-r02-r02-r03-r13-r13-r03-r06-r05), 
t79 (n = 1; r37-r03-r03-r06-r05), t80 (n = 1; r01-r21-r21-r21-r02-r03-r03-r06-r05), and t81 
(n = 2; r01-r09-r02-r02-r03-r13-r03-r13-r03-r06-r05). Two new dru types were identified 
and added to the database: dt11bl (n = 5; 5a-3c-4a-0-3c-5b-3a-2g-3b-4e-3e) and dt13x (n 
= 1; 5a-2d-4a-1d-3a-5b-3a-2g-6o-3a-2g-3b-4e). 
There was a strong association between SCCmec type and dru type (P < 0.0001) 
with dt9a over-represented for SCCmec type II-III, and dt11a and dt11af occurring with 
type V. The majority (7/8) of the type IV isolates that were sequenced were dt10h. Spa 
type and dru type were also strongly associated (P < 0.0001) with dt9a over-represented 
for t02, and dt11a and dt11af strongly associated with t06. There was no significant 
association with expA or expB carriage with the t06 and t02 spa types versus other types 
(P = 0.9782 and 0.1399, respectively).  There was also no significant association with 
expA or expB carriage with the three most common dru types (0.1387 and 0.3106, 
respectively). Spa type was not correlated with pyoderma or surgical site infections among 
all isolates (P = 0.5499 and 0.9498, respectively). The proportion of isolates collected 
from dogs with pyoderma was significantly (P = 0.0159; chi-squared test) greater among 
dt11af isolates (62%; 16/26) than other isolates (33%; 27/83), and the proportion of 
isolates that were from dogs with surgical site infections was significantly (P = 0.0017; 
chi-squared test) greater for dt9a isolates (44%; 8/18) than for other dru types (11%; 
10/91).   
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Conclusions 
This is the first study with > 200 isolates that has looked at ET gene prevalence in S. 
pseudintermedius isolates from dogs. Carriage of speta was universal and siet was carried 
by 99% of the isolates. These findings are similar to previous studies that found that all of 
the tested isolates carried speta and siet [112,115,131]. The overall prevalence of expA 
carriage was 12% and expB carriage was 16%. Previous studies have reported a 0-6% 
expA carriage prevalence and 0-10% expB prevalence [112,115,131]. In this study, expA 
and expB were always carried in conjunction with speta and siet. There was no correlation 
between carriage of expA or expB and sex, age, or breed, and the proportion expA or expB 
– positive isolates was similar between healthy and diseased dogs. Carriage of ET genes 
was not linked to SCCmec, spa, or dru type. The most common spa type in the MRSP 
isolates was t06, as has been observed in the majority of S. pseudintermedius isolates 
cultured in North America [9]. The overall MRSP prevalence in the collection was 32%, 
and the most common SCCmec, spa, and dru type combinations were V+t06+dt11a. There 
was no correlation between methicillin resistance status and carriage of expA or expB. This 
is the first study to determine that odds of pyoderma were greater for dogs that were expA-
positive when comparing healthy and diseased dogs.  
 
Inflammation scoring study 
The tissues examined included haired skin (n = 15), ear canal skin (n = 3), paw pad 
skin (n = 4), subcutis (n = 2), and unhaired skin (n = 1). The set included diseased dogs 
from the pyoderma (n = 6), surgical (n = 2), and other (n = 16) groups. There was a skin 
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biopsy from one dog in the healthy group that was evaluated for a small skin mass shortly 
after initial culture, and neoplasms were present in two additional cases. The majority 
(92%; 23/25) of the isolates in the paired cultures were MR. The carriage profiles for the 
paired biopsies included: speta+siet (n = 19), speta+siet+expA (n = 2), and 
speta+siet+expB (n = 4). The majority of the skin tissues were moderately inflamed (n = 
10), with fewer cases of mild (n = 5), severe (n = 8), or minimal (n = 2) inflammation. 
More cases had mononuclear type inflammation (n = 11) than polymorphonuclear 
inflammation (n = 9) or a mixture of the inflammation types (n = 5). The ratio between 
superficial (n = 11) and deep (n = 12) inflammation was similar; however, the depth of 
inflammation could not be assessed in two cases due to the absence of identifiable 
epidermis or superficial skin structures in the biopsy. Bacteria were visible in nine of the 
cases, all having the speta+siet ET carriage profile. 
The inflammation severity scores of the paired biopsies were correlated to the ET 
carriage profile of the associated bacterial isolates (P = 0.0002; FET) and to the type of 
inflammation (P= 0.0306; FET). The speta+siet profile was less likely to be associated 
with mild inflammation (P = 0.0001; two-tailed FET), and speta+siet+expA and 
speta+siet+expB were more likely to be associated with mild inflammation (P = 0.0333 
and 0.0162, respectively; two-tailed FET) when compared to other severity categories. 
When grouping moderate and severe inflammation together, speta+siet was more likely 
to be associated with severity scores > 1 (P = 0.0022; two-tailed FET). Inflammation 
scored as mild was more likely to be mononuclear when compared to other severity or 
inflammation type groups (P = 0.0087; 2-tailed FET). The speta+siet profile was less 
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likely to be associated with mononuclear inflammation than other ET profiles (P = 0.0026; 
two-tailed FET), and speta+siet+expB was more likely to be associated with mononuclear 
inflammation (P = 0.0261; two-tailed FET). Depth of inflammation was correlated with 
the severity score (P = 0.0094; FET), with mild inflammation linked with a superficial 
distribution (P = 0.0373; two-tailed FET) and severe inflammation linked to a deep 
distribution (P = 0.0272; two-tailed FET). Inflammation depth was not correlated to ET 
carriage profile (P = 0.2880; FET), and methicillin-resistance status was not correlated 
with any of the examined histologic indices.  
Drawbacks to the inflammation scoring study included the small sample size of 
only 25 out of the 475 dogs (5.3%) in the ET prevalence study that had paired biopsies to 
examine, paucity of the expA and expB carriage profiles, and uncertainty that the biopsies 
and cultures were taken from similar regions. The isolates associated with the paired 
biopsy set were almost exclusively MR, which could have also biased the results. Contrary 
to our hypothesis, the speta+siet profile was correlated with inflammation severity scores 
greater than 1 (moderate and severe) and the speta+siet+expA and/or speta+siet+expB 
carriage profiles were correlated with mild or mononuclear inflammation.  
One explanation for these observations is that there are likely other virulence 
factors besides ET expressed in acute (i.e. predominately polymorphonuclear) skin 
lesions, and the tendency for expA and expB carrying isolates to be associated with mild 
or mononuclear inflammation suggests ET may have a role in chronic skin lesions. That 
mild inflammation is more correlated with mononuclear inflammation in our analyses may 
be due to differences in presentation of acute vs. chronic pyoderma. The correlations 
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between depth and severity of inflammation are expected as more severe lesions often 
encompass more tissue area and descend to deeper layers/structures within the skin.  
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CHAPTER IV 
NATIVE INDUCTION OF S. PSEUDINTERMEDIUS EXFOLIATIVE TOXIN 
EXPRESSION AND ANTIBODY PRODUCTION IN DOGS 
 
Introduction 
Experiments with recombinant S. pseudintermedius EXPA have demonstrated that 
it degrades the extracellular domains of canine Dsg1, mouse Dsg1α, and swine Dsg1 but 
not degrade human Dsg1 or mouse Dsg1β and Dsg1γ [88]. Recombinant SIET does not 
degrade canine, mouse, human, or swine Dsg1 [88]. Recombinant EXPB degraded 
recombinant extracellular domains of canine Dsg1 but it has not been tested against Dsg1 
from humans or other species [125]. SIET, EXPA, and EXPB do not degrade the deeper 
desmoglein-3 anchoring proteins [88]. The structural properties and target site of SPETA 
have not been determined [89]. Comparison of the predicted protein structures of the S. 
pseudintermedius SIET, EXPA, and EXPB proteins have revealed that the toxins have 78, 
68, and 70% homology with SHETA, ETD and SHETB toxins, respectively, with lesser 
homology to ETA and ETB [89]. The protein structure of SPETA has not been evaluated. 
Based on the predicted target site of S. pseudintermedius ET and the homology to ET in 
other bacterial species, the S. pseudintermedius ET are presumed to be secreted outside 
the cell as exotoxins. While recombinant SIET, EXPA, and EXPB proteins have been 
made and expressed in Escherichia coli in other studies [88,124,125,134], none have 
looked at native ET protein expression in S. pseudintermedius isolates in vitro. Also, it is 
unknown if dogs with and without pyoderma produce antibodies to the S. 
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pseudintermedius ET. As the conditions that facilitate native expression of ET were 
unknown in S. pseudintermedius, we modeled our study on previous work with native 
ETA expression in S. aureus [135]. The expected molecular weights of recombinant 
EXPA and EXPB are 27.5 and 26.9 kDa, respectively [88,124,125]. The molecular weight 
of recombinant SIET has been reported as 30 [134] and 45 kDa [88]. The molecular weight 
of the synthetic GFP versions used in the Set 1 plasmids for this experiment are 27 (SIET 
and EXPB) and 30 kDa (EXPA), and the expected weights of the EXPA+GFP, 
EXPB+GFP recombinant proteins for Set 1 are 58, 54 kDa, and 57-72 kDa, respectively. 
Due to difficulties in purification of the Set 1 recombinant EXPA and EXPB (see Materials 
and Methods), the expA and expB genes were codon optimized and also cloned into 
another plasmid vector to facilitate protein purification (Set 2). The purpose of this 
experiment was to determine the conditions under which S. pseudintermedius isolates 
secrete SIET, EXPA, and EXPB, and to determine if dogs produce anti-SIET, -EXPA, and 
–EXPB antibodies. 
 
Materials and methods 
Production of primary anti-ET antibodies 
In order to detect unlabeled, native ET proteins in culture supernatant, we 
contracted with LifeTein® LLC (Somerset, NJ) to produce affinity purified primary anti-
SIET, -EXPA (EXI), and -EXPB antibodies. Two rabbits were immunized twice with 
synthetically produced peptide fragments representing the epitopes that were predicted to 
be the most antigenically stimulating, yet specific for each ET protein (Table 2). As 
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SPETA was present in every isolate tested and had few epitopes to target for optimal 
antibody production, we did not include this protein in the expression studies.  
 
 
 
Protein Peptide Sequence  
SIET ATSTVLEEGDSNKKIAEI-C 
EXPA C-KNVTTLGEDLKKRAKLQEE, 
includes a N-terminal KLH 
conjugation 
EXPB AKTYDEAEIIKKRDSFNTS-C 
 
Cloning Primers (SIET and EXPB) 
Siet F (NdeI)- 
AAGGAGATATACATATGATGTCAAA
AAGGATCATAGCG 
Siet R (NheI)- 
GGTTTTCACCGCTAGCCCCTTCAT
ATTTGTACATTGG 
ExpB F (NdeI)- 
AAGGAGATATACATATGATGAATAA
AACTACTTTTAAACAT 
ExpB R (NheI)- 
GGTTTTCACCGCTAGCATCTTCTG
ATTCAGCTCTTTT 
 
Table 2: Synthetic peptide and cloning primer sequences for the Set1 SIET and 
EXPB proteins. 
 
 
 
Recombinant ET protein control production 
Recombinant ET proteins (Set 1 and Set 2) were made for use as controls for the 
native expression experiments. All plasmids used were pET expression vectors which 
utilized the T7 promoter for T7 RNA polymerase, encoded either ampicillin/carbenicillin 
(pET15) or kanamycin resistance (pET28), and allowed for induced expression of the 
proteins through addition of isopropyl β-D-1-thiogalactopyranoside (IPTG) to the media.  
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Set 1 
Recombinant SIET and EXPB were made by cloning the native S. 
pseudintermedius DNA coding region (reference ADX76359.1 and AB569087.1, 
respectively) for each of the proteins into a pET15b backbone plasmid containing a C-
terminal tobacco etch virus (TEV) protease cut site, fusion with superfolder green 
florescent protein (GFP), and a 6x His tag [136]. The plasmids were linearized with NdeI 
and NheI, and the ET gene inserts were amplified via PCR with 5’ and 3’ hanging (“sticky” 
ended) primers (Sigma-Aldrich, St. Louis, MO) containing the specific cut sequences for 
the restriction enzymes used (Table 2). The inserts were ligated using the In-Fusion® HD 
Cloning Kit (Clontech Laboratories, Inc.). Due to an intrinsic TEV protease cut site in 
EXPA, a pET backbone plasmid was designed and produced by VectorBuilder (Cyagen 
Biosciences Inc., Santa Clara, CA) containing an E. coli codon optimized open reading 
frame for EXPA (AB489850) within the multiple cloning site followed by a C-terminal 
enterokinase cleavage site, fusion to GFP, and a 6x His tag. The ligated SIET+GFP, 
EXPB+GFP, and EXPA+GFP plasmids were transformed into Novablue competent E. 
coli cells (Invitrogen) and plated onto 50 µg/mL carbenicillin plates. White colonies were 
selected and checked via PCR targeting the T7 promoter region for appropriate in-frame 
incorporation of the inserts based on Sanger sequencing (Eton Biosciences, Inc.).  
Plasmids were purified using a Qiagen mini-prep plasmid kit using the standard 
protocol and were transformed into E. cloni® EXPRESS BL21(DE3) Chemically 
Competent Cells (Lucigen Corp., Middleton, WI). To induce recombinant ET expression, 
20 mL cultures were grown until OD600 was 0.6 to 0.8, whereby 1 mM final concentration 
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(20 µL) of IPTG was added to the culture and the culture was incubated at room 
temperature overnight (12 h). The bacterial pellets were then lysed with BugBuster® 
Protein Extraction Reagent (EMD Millipore, Darmstadt, Germany) and the whole cell 
lysate was used in subsequent experiments to test anti-ET antibody specificity in the 
presence of bacterial extract from a non-staphylococcal species. Purification of the Set1 
recombinant proteins using a nickel-charged affinity resin column (Ni-NTA Agarose; 
Thermo-Fisher Scientific) was unsuccessful, necessitating re-cloning and further 
expression experiments with EXPA and EXPB (see Set 2). Due to the results of some of 
the preliminary native ET expression experiments (see below), further purification of the 
recombinant SIET was not pursued. 
 
Set 2 
 The coding DNA of expA and expB were codon optimized using the Codon 
Optimization Tool (http://www.idtdna.com/CodonOpt) and synthesized as gBlocks gene 
fragments (Integrated DNA Technologies, Coralville, Iowa). The synthesized expA and 
expB gene fragments were cloned into a pET28b-based vector (Agilent Technologies) 
with an N-terminal fusion with maltose binding protein (MBP), a 6x N-terminal His tag, 
and a TEV cleavage site between the 6xHisMBP tag and the ET protein sequences. The 
pET28b plasmids were linearized with BamHI and XhoI and the fragments were ligated 
into the plasmid backbone with T4 DNA ligase. The resulting plasmid was checked for 
proper, in-frame integration of the insert through DNA sequencing. The E. coli strain 
BL21Star (DE3) (Invitrogen) was co-transformed with the pET28b/6HisMBP-EXPA and 
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-EXPB expression plasmids and pLysSRARE2 plasmid (Agilent Technologies) and 
grown overnight in Terrific Broth (tryptone, yeast extract, and glycerol) containing 
chloramphenicol (34 µg/mL) and kanamycin (50 µg/mL) at 37ºC. The overnight culture 
was used to inoculate Terrific Broth containing kanamycin (50 µg/mL) and incubated 
while being shaken at 37 ºC until the OD610 reached 0.8. The culture was then chilled to 4 
ºC, 1 mM of IPTG was added, and the culture was shaken for 24 hours at 22 ºC. Cells 
were harvested by centrifugation at 6000 × g for 10 min. 
 
Purification of EXPA and EXPB from Set 2 
The induced Set 2 MBP+EXPA and MBP+EXPB cell pellets were re-suspended 
in purification buffer (50 mM Tris/HCl, pH 8.0 containing 300 mM NaCl, 20 mM 
imidazole, and 10% glycerol). The homogeneous suspension was lysed with 4-5 passes 
through a M-110P Microfluidizer® (Microfluidics, Westwood, MA) at 20,000 psi, and 
then centrifuged at 4 ºC for 30 min at 30,000×g. The supernatant was then applied onto a 
HisTrap™ 5-mL column (GE Healthcare, Little Chalfont, United Kingdom), and eluted 
with purification buffer containing 500 mM imidazole, which was then removed by using 
a HiPrep™ 26/10 Desalting (GE Healthcare) on the ÄKTA pure chromatography system 
(GE Healthcare). The purified 6HisMBP-EXPA and -EXPB was then digested with TEV 
at a ratio of 6.67 µg of TEV per mg of recombinant protein overnight at 4 ºC, and was 
then loaded onto a HisTrap™ 5-mL column; the flow-through was harvested and 
concentrated, and then was loaded onto a HiLoad® 16/600 Superdex® 200 pg column 
(GE Healthcare) which was pre-equilibrated with size-exclusion buffer (TBS, pH 7.4) for 
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gel filtration on the ÄKTA pure system. The fractions containing tag-free EXPA and 
EXPB were pooled and concentrated by using Amicon Ultra-15 Centrifugal Filters with a 
10,000 Da nominal molecular weight limit (Merck Millipore, Billerica, MA). The purity 
of the tag-free EXPA and EXPB was checked via 4-20% sodium dodecyl sulfate –
polyacrylamide gel electrophoresis (SDS-PAGE) and Coomassie blue staining. The 
protein concentration was determined by DC Protein Assay with a Bio-Rad (Hercules, 
CA) kit, using bovine serum albumin as the standard. 
 
Antibody specificity experiments 
The specificity of the anti-ET antibodies was tested via dot blot and Western blot 
using the synthetic peptides provided by LifeTein® LLC and the E. coli recombinant ET 
proteins from Set 1 and 2 as positive controls. Samples were tested with nitrocellulose and 
polyvinylidene difluoride (PVDF) membrane of 0.45 and 0.2 µM pore sizes. Lyophilized 
SIET, EXPA, and EXPB synthetic peptides were diluted in phosphate buffered saline (pH 
7.0) and either dotted onto nitrocellulose membrane (pore size 0.2 µM) or transferred to a 
PVDF (pore size 20 µM) membrane for Western Blot. For Western Blot, samples 
(peptides, bacterial lysate from Set 1, and purified Set 2 recombinant proteins) were mixed 
1:1 with 2X Tris-glycine-SDS loading buffer and heated to 85°C for 10 min. EXPA and 
EXPA peptide controls were only heated briefly (< 1 min) to avoid complete proteolysis 
of the small fragments and SIET peptide was not heated at all. The samples were loaded 
onto a NuPAGE™ 4-12% Bis-Tris, 1 mm-thick protein gel (Thermo-Fisher) and 
electrophoresed in 1X 3-(N-morpholino) propanesulfonic acid (MOPS) buffer at 170V for 
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60 min in an XCell SureLock™ Mini-Cell Electrophoresis System (Thermo-Fisher 
Scientific). The proteins were transferred from the gel onto prepared PVDF membrane in 
chilled Towbin buffer at 100V for 60 min with a Mini-PROTEAN® electrophoresis 
system (Bio-Rad). The PVDF membrane was blocked for 1 h with TTBS buffer (50 mM 
Tris-HCL (pH 7.4), 150 mM NaCl, and 0.1% Tween 20) + 5% powdered non-fat skim 
milk. Primary antibody was added at a dilution of 1:5500 in TTBS + 5% non-fat skim milk 
buffer and incubated with gentle rocking at 4°C for 12-14 h. The membrane was washed 
with TTBS three times at 15 min, and secondary goat anti-rabbit IgG horseradish 
peroxidase conjugated antibody (31460; Thermo-Fisher Scientific) was added at a 1: 
200,000 dilution and incubated at room temperature for 1 h. The membrane was washed 
in TTBS three times for 10 min before 0.5 mL each of SuperSignal™ West Pico 
Chemiluminescent Substrate (Thermo-Fisher) parts A and B were added and incubated 
with agitation for 5 min. Membranes were wrapped in cellophane wrap and exposed to x-
ray film for 30 min to 1 hr. For dot blots, 3-5 µL of sample was dotted onto either 
nitrocellulose or prepared PVDF membrane and left to dry for 1 hr before blocking and 
processing as described for the Western blots. The controls (Fig. 3) demonstrated bands 
of expected size for the peptides or fusion with GFP on Western blot (individually tested 
and in combination with all three anti-ET antibodies). 
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Figure 3: Peptide and recombinant ET protein controls.  
A: Dot blot on nitrocellulose (0.2 µM) membrane of ET peptides using anti-SIET (top), 
EXPA (middle), and EXPB (bottom) antibodies. 1 = SIET, 2 = EXPA, and 3 = EXPB 
B: Western blot on PVDF (0.2 µM) membrane of Set 1 recombinant GFP+ET proteins 
(50 ng lysate loaded) using anti-SIET, EXPA, and EXPB antibody cocktail. The larger 
bands represent fusion of GFP with the ET proteins and the smaller bands are ET protein 
separated from GFP. 1 = Molecular weight marker (GE Healthcare; RN756E), 2 = 
GFP+SIET, 3 = GFP+EXPA, 4 = GFP + EXPB 
C: Western blots on PVDF (0.2 µM) membrane of Set 2 purified, untagged EXPA and 
EXPB (20 ng loaded) with anti-EXPA (left) and -EXPB (right) antibodies. 1 = Molecular 
weight marker (SMBio; PM2500), 2 = LB broth blank, 3 = EXPB, 4 = EXPA 
  
 
 
Induction of native ET production in select S. pseudintermedius isolates 
Isolates representing each of the ET carriage combinations were tested (i.e. speta-
only, speta+siet, speta+siet+expA, etc.). The following represents the protocol that 
produced the most consistent expression of ET, although other permutations were tested. 
A single colony was inoculated into 1 mL of full salt lysogeny (i.e. Luria-Bertani) broth 
in a 5 mL glass test tube with a side-ventilated plastic cap that was loosely fitted. The 
cultures were incubated with 10% CO2 and agitation on a 2D orbital shaker at 200 rpm in 
a water jacketed incubator with water pan (Forma Scientific; Thermo-Fisher). The 
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incubator was initially at room temperature (22 °C) and slowly warmed to 37°C over the 
course of 2 h; the cultures were incubated for 12-14 h. The bacterial culture was pelleted 
by centrifugation at 5,510 x g for 15 min, the supernatant was removed and filtered with 
a 0.45 µm syringe filter, and the supernatant was chilled for 1-2 h at 4°C. Ice-cold 
trichloroacetic acid (TCA) 6.1 N solution (250 µL) was added to each reaction and the 
samples were cooled at 4°C for 1 hr. Samples were centrifuged in 1.5 mL conical 
Eppendorf tubes at 14,000 x g at 4°C for 20 min. The TCA supernatant was removed using 
wide-mouth 1 mL pipette tips, the protein pellets were re-suspended in ice cold acetone 
two times, and the mixture was centrifuged at 14,000 x g, at 4°C for 10 min. The pellets 
were dried for 10 min at 80 °C before resuspension in 30 µL of phosphate buffered saline 
(pH 7.0). Concentrated supernatant was used for dot blot or Western blot as described for 
the antibody specificity experiments, except 50 ng of Set 1 bacterial recombinant protein 
lysates or 20-50 ng of purified EXPA and EXPB protein were used as controls and the 
blots were exposed to x-ray film for up to 2 hours to optimize exposure due to the low 
concentration of ET protein in the native expression samples. Paired gels were also stained 
with Coomassie blue to visualize all of the protein bands in the samples used for the 
Western blots. 
 
Antibody production to EXPA and EXPB in dogs  
 Serum from thirteen dogs with a clinical history of pyoderma or history of culture 
of S. pseudintermedius (pyoderma/exposure group) and thirteen dogs that presented for 
other was conditions obtained for the study (control group). Dogs in the control group 
 49 
 
presented for orthopedic (n = 4), urinary (2), neurologic (2), hepatic (1), neoplastic (2), 
endocrine (1), and cardiovascular (1) conditions. All serum samples were residual 
diagnostic specimens and were collected under the ethical and standards of care guidelines 
for the Texas A&M Veterinary Medical Teaching Hospital (VMTH). The criteria for 
inclusion in the pyoderma/exposed group were either mention of dermatitis, pyoderma or 
allergic skin disease in the major problem list in the clinical record (n = 10) or culture of 
S. pseudintermedius from the skin (n = 3) or another body site (n = 3; one each from 
cornea, lung, and ear). Two dogs in the pyoderma/exposure group contributed isolates in 
the ET prevalence study (speta+siet and speta+siet+expB phenotypes). ET protein control 
samples (1 µg of Set 2 purified EXPA and EXPB and 1 µg of Set 1 GFP+SIET lysate) 
were heat denatured and run on a NuPAGE™ 4-12% Bis-Tris, 1 mm-thick protein gel 
(Thermo-Fisher) and processed for Western blot as described in the antibody specificity 
experiment methods. A gel with the samples was also stained with Coomassie Brilliant 
Blue. The EXPA and EXPB purified protein did contain a small amount of the MBP tag 
(45 kDa) that was visible on the Coomassie stained gel (see below) and served as a 
negative protein control in addition to an LB blank in one lane. Pooled pyoderma/exposure 
and control serum samples containing 100 µl of serum from individual dogs in the groups 
were used as the primary antibodies and were diluted 1:1,000 in TTBS, and the PVDF 
blots were incubated at 4°C overnight (12 h) with gentle rocking. The blots were washed 
in TTBS 3x for 15 min and then incubated with secondary goat anti-canine IgG antibody 
conjugated with HRP (A18763; Thermo-Fisher Scientific) at 1:10,000 dilution at 22°C for 
60 min. The blots were washed 3x in TTBS for 10 min before 0.5 mL each of 
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SuperSignal™ West Pico Chemiluminescent Substrate (Thermo-Fisher) parts A and B 
were added and incubated with agitation for 5 min. Membranes were wrapped in 
cellophane wrap and exposed to x-ray film for up to 3 hr. 
 
Results and discussion 
Native ET induction  
Expression of EXPB and EXPA was observed for the single and dual carriage 
isolates with bands that corresponded to the predicted sizes for each of the proteins. SIET 
was only labeled in the synthetic peptide controls on nitrocellulose dot blot and in the 
recombinant SIET+GFP protein, and native expression of SIET was not observed in the 
tested S. pseudintermedius samples (results summarized in Fig. 4) using a protocol that 
induced expression of EXPA and EXPB. Two faint bands were seen on the SIET blots in 
speta +siet + expA and speta + siet +expB carriage isolates at approximately 20 kDA, but 
this product is smaller than the predicted size of SIET and likely represents background 
staining. The SIET peptide degraded quickly and did not transfer well to PVDF membrane 
for Western blot; interestingly, the native induction and lysed bacterial Set 1 control 
samples did not transfer well to nitrocellulose membrane of either pore size, and were 
instead best observed on PVDF. This difference was most likely due to buffer differences 
in the lysis and resuspension buffers of the samples. While exact quantification of the 
amount of EXPA and EXPB secreted into the supernatant could not be performed due to 
the need to concentrate the protein to visualize on the Western blot, the amount of signal 
achieved in the bacterial samples was comparable to the amount of signal achieved when 
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20 ng of the purified protein controls were loaded onto the gel. This finding suggests that 
EXPA and EXPB production can be induced in S. pseudintermedius and at least 20 ng of 
the ETs can be produced per 1 mL of bacterial supernatant under the experimental 
induction conditions outlined in this experiment. This study represents the first time native 
expression of ET has been attempted in S. pseudintermedius and suggests that EXPA and 
EXPB are secreted in significant amounts outside of the bacterial cell. 
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Figure 4: Native induction of SIET (top), EXPA (middle) and EXPB (bottom) in S. 
pseudintermedius isolates. Western blots of S. pseudintermedius samples and controls. 
 
1 = Protein Molecular weight marker 
(SMOBio; PM2500) 
2 = speta only (12-017) 
3 = speta + siet (19-040) 
4 = speta + siet + expA (37-029) 
5 = speta + siet + expB (19-008) 
6 = speta + siet + expA + expB (33-
100) 
7 = LB blank 
8 = dH2O 
9 = SIET peptide 
10 = EXPA peptide 
11 = EXPB peptide 
12 = Set 1 
pET15+SIET+GFP+6xHis 
(bacterial lysate) 
13 = Set 1 
pET15+EXPA+GFP+6xHis 
(bacterial lysate) 
14 = Set 1 
pET15+EXPB+GFP+6xHis 
(bacterial lysate) 
15 = Protein molecular weight marker 
(GE Healthcare; RN756E) 
16 = speta + siet + expA + expB (29-
002) 
17 = Set2 purified EXPA (20 ng 
untagged) 
18 = Set2 purified EXPB (20 ng 
untagged) 
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Canine serum samples 
Sera from the pyoderma/exposed and control dog groups contained antibodies to 
purified Set2 EXPA and EXPB (Fig. 5), with antibodies in the pyoderma group also 
binding to a band of the approximate size of the recombinant SIET+GFP from Set 1 as 
well as multiple proteins in the E. coli bacterial lysate. The band intensity was greater in 
sera from the pyoderma/exposure group when compared to sera from the control group, 
but there was still appreciable binding of antibody to the EXPA and EXPB proteins in the 
control group. This finding suggests that dogs without a reported history of clinical 
pyoderma were also exposed to and produced antibodies to ET. The greater intensity of 
binding to the EXPB protein in the pyoderma group could be explained by the one 
individual in that group with known exposure to EXPB based on the prevalence study 
data. Other considerations are that the clinical histories of the dogs in the control group 
could have been incomplete or a few individuals previously had clinical or subclinical 
pyoderma or the dogs were exposed to S. pseudintermedius ET via another route (i.e. 
mucous membrane exposure and/or ingestion). These results show that dogs can produce 
an antibody response to EXPA and EXPB, and dogs with a history of pyoderma/ exposure 
to S. pseudintermedius may also produce antibodies against SIET. 
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Figure 5: Antibody production against ET in dogs. Western blot using sera from dogs 
without a history of pyoderma (middle) and dogs with a history of pyoderma or culture of 
S. pseudintermedius (right). The black arrow indicates the approximate size of the 
SIET+GFP band in the induced E. coli bacterial lysate on the Coomassie Brilliant Blue 
stained SDS-PAGE gel (left). The MBP tag is indicated by the white arrow in lanes 2 and 
3 in the Coomassie gel, which the canine sera antibodies did not bind to in either test 
group. 
 
1 = Protein Molecular weight marker (SMOBio; PM2500) 
2 = Set 2 purified EXPA (untagged, 1 µg) 
3 = Set 2 purified EXPB (untagged, 1 µg) 
4 = LB blank 
5 = Set 1 pET15+SIET+GFP+6xHis (bacterial lysate) 
 55 
 
CHAPTER V 
EXFOLIATIVE TOXIN GENE MAPPING IN S. PSEUDINTERMEDIUS ISOLATES  
 
Introduction 
Virulence genes in other species of staphylococci are frequently carried on MGE  
that are transferred through plasmids, transposable elements, or phages that facilitate 
horizontal transfer of virulence factor genes between bacteria and contribute to the 
development of antimicrobial resistance [83]. For instance, S. aureus ETB and S. hyicus 
SHETB are both encoded on plasmids, and other staphylococcal exotoxins, such as ETA, 
are carried on phage [83]. ET gene expression is controlled by regulators, such as the agr 
regulatory group, which influences expression of ETA and ETB in S. aureus [137]. In 
previous studies in S. aureus, ET producing strains have been closely related and are 
usually linked with the agr type IV allele [80], but it is not known if agr allele type differs 
among ET-carrying strains of S. pseudintermedius. 
Previous studies with the siet, expA, and expB genes have determined that they are 
not carried on plasmids [88,125]. Three of the four purported ET genes are found within 
the S. pseudintermedius reference genomes within GenBank. The siet gene is positioned 
on the chromosome between the transmembrane protein YfcA and a thiol peroxidase. The 
speta gene is adjacent to a phage encoded chromosome degrading nuclease YokF (also 
known as uncharacterized protein YhjA; position 68,188- 69,103 in HKU10-03 reference 
genome). Both speta and siet are consistently located in these regions on the chromosome 
in the 18 S. pseudintermedius reference genomes available at GenBank and do not appear 
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to be associated with MGE. The only sequence giving any context to the position of expA 
within the S. pseudintermedius chromosome is a partial sequence in the incomplete, 
unindexed 2001-08-299-1 strain draft genome (ASM162294v1). The expB gene is not 
present within the reference genomes at GenBank and has not been mapped. It is unknown 
if expA or expB are located on MGE that may facilitate horizontal transmission of the 
genes. The purpose of this analysis was to map the expA and expB genes within the 
chromosome and to determine if they were associated with MGE. The MLST and agrD 
auto-inducible protein sequence typing schemes developed for S. pseudintermedius 
[71,138] were also determined for the 13 examined isolates. 
 
Materials and methods 
Bacterial culture and DNA extraction 
 Two isolates that carried expA and expB, one isolate that carried speta + siet, and 
five isolates that carried either expA or expB were chosen for sequencing (Table 3). The 
isolates were struck onto blood agar from the freezer stock vials (LB with 20% glycerol) 
and incubated at 37 °C for 12 h; the culture was sub-cultured onto another blood agar 
plate. Finally, a single colony was used to inoculate 1 mL of brain-heart infusion broth 
(BHI) and the culture was incubated at 37 °C for 12 h on an orbital shaker set at 200 rpm. 
The cultures were transferred to 1.5 mL, plastic conical bottom Eppendorf tubes, and the 
bacteria were pelleted by centrifugation at 6000×g for 10 min and the supernatant was 
removed. DNA was extracted using a MasterPure™ Gram Positive DNA Purification Kit 
(Epicentre; Madison, WI) according to the manufacturer’s recommendations for S. aureus 
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DNA extraction, except the samples were incubated at 37 °C for 12 h at the lysis buffer 
step and the DNA pellets were resuspended in 30-60 µL of elution buffer at the elution 
step.   
 
 
ET gene 
profile 
Isolate # Methicillin 
resistance 
status 
Spa type Group 
expA 29-095 MS NA Urine 
30-085 MS NA Healthy 
38-056 MS t06 Pyoderma 
37-029 MS t06 Pyoderma 
41-073 MS t06 Surgical 
expB 12-005 MS t05 Surgical 
30-090 MS t76 Pyoderma 
31-062 MS t07 Pyoderma 
37-024 MS NA Urine 
39-026 MR NA Pyoderma 
expA + expB 29-002 MS NA Healthy 
33-100 MS t06 Urine 
speta + siet 19-040 MS t02 Urine 
 
Table 3: Characteristics of 13 S. pseudintermedius isolates used for WGS. MR = 
methicillin-resistant, MS = methicillin sensitive. 
 
 
 
Whole genome sequencing 
The recommended minimum depth of sequencing required for de novo assembly 
of Escherichia coli genomes is 50-fold, and this coverage benchmark is recommended for 
WGS of other small bacterial genomes as higher magnitude coverage can result in 
pseudogene amplification within runs [139]. Sequencing libraries were prepared using the 
NEXTflex® Rapid DNA-Seq Library Prep Kit for Illumina® Sequencing (Bioo Scientific, 
Austin, TX). DNA was quantified using the Qubit™ 2.0 (Life Technologies, Carlsbad, 
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CA) high sensitivity double stranded DNA (dsDNA) assay and all samples were 
normalized to 100 ng of DNA in a total volume of 14 µL. Five microliters of normalized 
DNA (1 ng total DNA) was used for library preparation. Prepared libraries were checked 
with the Qubit™ 2.0 dsDNA assay to determine concentration and a TapeStation D1000 
HS (Agilent Technologies, Santa Clara, CA) was used to determine the average fragment 
size of the prepared libraries. All samples were normalized to 4 nM and all samples were 
pooled together for sequencing. The 4 nM pool was diluted to 20 pM and sequenced on 
the Illumina® MiSeq 300 x 300 cycle v3 sequencing kit. All run data and FASTQ files 
were uploaded to BaseSpace (https://basespace.illumina.com/) for downstream analysis.   
 
Genome assembly and annotation  
The Illumina® MiSeq paired read libraries for each isolate were de novo 
assembled using the careful mismatch correction option in SPAdes (v. 3.6.2). The online 
sequencing pipeline offered by the Pathosystems Resource Integration Center (PATRIC 
version 3.4.6; https://www.patricbrc.org) was used to annotate the genomes [140]; 
annotation was done using the Rapid Annotation using Subsystem Technology tool kit 
(RASTtk) on the PATRIC pipeline [141]. 
 
Analysis of ET gene position and identification of MGE 
The SPETA (ADX77621), SIET (CAR57917.1), EXPA (BAI49625.1), and EXPB 
(BAJ23893.1) amino acid sequences available at UniProt (http://www.uniprot.org/) were 
queried against the NCBI reference database using the protein BLAST available in the 
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PATRIC interface. The nucleotide and amino acid sequences for expA and expB in 
respective isolates were compared using the multi-sequence alignment tool in PATRIC. 
The locations of all four ET genes within the annotated genomes were analyzed with the 
Compare Region Viewer in PATRIC, and the ET gene regions were compared with the S. 
pseudintermedius reference genome HKU10-03 and amongst the different ET carriage 
groups. The contigs containing EXPA and EXPB in the sequenced isolates were analyzed 
with the online resources PHAST and PlasmidFinder 1.3 to identify prophage elements 
and plasmid origins of replication, respectively [142,143]. To find pathogenicity island 
(PI) components, contigs containing ET genes were queried using the online Pathogenicity 
Island Database (PAI DB version 2.0; http://www.paidb.re.kr/search_blast.php) [144].  
 
MLST, agr determination, and presence of selected virulence genes 
 MLST was assigned in silico based on the previously described method using the 
assembly files for selected isolates and the batch query function of the online BIGSdb 
genomics MLST platform for S. pseudintermedius [71,78]. New types were submitted for 
inclusion in the database. Grouping into CC was performed with the eBURST algorithm 
in the BIGSdb database using all S. pseudintermedius isolates deposited in the database as 
of October 2017. Sequences for SEA, SEB, SED, and TSST-1 available in the 
staphylococcal VirulenceFinder 1.5 database files provided by the Center for Genomic 
Epidemiology (current as of March 2017) were used as reference sequences for the 
PATRIC BLAST queries [145]. The agr type was assigned by PATRIC BLAST query of 
the amino acid motifs unique to each type: I- RIPTSTGFF, II- KIPTSTGFF, III- 
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RIPISTGFF, and IV- KYPTSTGFF [114]. The sequences reported for LukSF-I [99], 
seccanine, se-int [109,110], and BacSp222 bacteriocin [100] were also queried. 
 
Results and discussion 
ET gene mapping 
Speta and siet 
 There was one significant single nucleotide mutation in the speta gene shared by 
three isolates (38-056, 30-090, and 39-026) that resulted in a phenylalanine to leucine 
amino acid substitution at position 294. There were two mutations in the siet gene that 
resulted in missense mutations in the protein sequence: in two isolates 37-029 and 30-090, 
there was a single nucleotide substitution that resulted in an alanine to threonine amino 
acid substitution at position 79, and in seven isolates there was an arginine to lysine 
substitution at position 185. The consequences of these mutations on the function of 
SPETA and SIET warrants further study as the substituted amino acids are of a different 
functional class than the replaced amino acid in the reference sequence. The speta gene 
was consistently downstream of the yhjA protein gene (Fig. 6A) and a lipase precursor, 
but the genes flanking the downstream region of speta were variable. In one of the expB 
isolates (31-062), the downstream region to speta contained several proteins associated 
with 70-90% homology to PI proteins in S. aureus SaPIbov (integrase- AF217235) and 
SaPI1 (terminase- U93688). The isolate 33-100 also had an identical integrase protein to 
the one found in 31-062. Carriage of the speta gene does not appear to be associated with 
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these elements as speta occurs in the same position in the genome regardless of concurrent 
carriage of the predicted PI-associated proteins. 
The siet gene was flanked by the same genes (Fig. 6B) in all of the S. 
pseudintermedius genomes sequenced, and the position between transmembrane protein 
YfcA and a thiol peroxidase was the same as reported in the HKU10-03 reference genome. 
No plasmid replication, phage-like proteins, or proteins associated with PIs were 
identified in regions of the contigs upstream or downstream of the siet gene in all of the 
sequenced isolates and reference genome. 
 
Figure 6: Position of speta (A) and siet (B) in selected genomes of S. 
pseudintermedius. Selected genes are labeled as annotated in PATRIC and the same 
color indicates the same gene in each line. The positions of speta and siet are indicated 
in red. The arrows indicate the direction of the open reading frame of the gene (i.e. 5’ 
to 3’ direction). HKU10-03 is the S. pseudintermedius reference genome. 
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ExpA 
The nucleotide and amino acid sequences for expA were identical in the single and 
dual carriage groups to the expA reference sequence (AB489850). The expA sequence in 
all of the examined isolates was adjacent to a reverse transcriptase retroelement (annotated 
as a retron-type RNA-directed DNA polymerase) that contained numerous tRNA repeat 
regions and an uncharacterized mobile element protein, and expA was downstream of 
recombination and repair protein (RecF), DNA gyrase subunits, and threonine 
dehydratase. A NCBI BLAST-p search of the retroelement protein sequence revealed that 
the element has 95% identity with a Group II intron reported in S. pseudintermedius as 
opposed to a true retron-type system. Group II introns are MGE that encode reverse 
transcriptase and are the only retroelements capable of non-GTP-mediated intron excision 
(i.e. autonomous mobility) [146]. Group II introns are rarely observed in staphylococcal 
genomes, but one to two copies have been identified in the HKU10-03 S. 
pseudintermedius reference genome [147]. In previous cases with other species of 
bacteria, insertion of Group II introns has not been associated with the presence of specific 
genes, but they may influence expression of downstream genes or trigger recombination 
events of genes within adjacent regions [148]. Interestingly, identical group II intron-like 
sequences were adjacent to expA in all of the genomes that carried expA, suggesting that 
this retroelement has an important role in transfer of expA. In six of the isolates, only the 
region upstream to expA was completely sequenced which is most likely caused by poor 
alignment within the repetitive elements in the retron RNA domain sequence, a frequently 
observed problem with short-read WGS methods. The only sequence containing the region 
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downstream of expA was in isolate 29-002. However, BLAST search of other elements in 
the 29-002 sequence revealed identical regions in the genomes of the other isolates 
carrying expA, which suggests that the sequence in 29-002 is representative of the region 
downstream of expA. PHAST queries of the upstream and downstream regions to expA 
did not reveal any components that were similar to known phage-related proteins or 
elements, and a PlasmidFinder query did not reveal any plasmid origins of replication in 
the areas. A PAI DB BLAST search of the downstream 29-002 sequence revealed an 
integrase-like protein with 82% sequence identity with an unnamed integrase protein 
(AAG29618.1) in S. aureus PI SaPIbov; no elements in the upstream expA sequences in 
the other expA carrying isolates returned hits via PAI DB BLAST query. Further 
investigation is needed to bridge the areas of the genome flanking the expA gene (Fig. 7) 
and to determine if the Group II intron or integrase sites may influence excision or 
insertion of expA in the genome. This could be accomplished by utilizing long-read WGS 
methods (i.e. nanopore sequencing) or Sanger sequencing to resolve the repetitive regions 
and join the predicted upstream and downstream sequences. 
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Figure 7: Position of expA in isolates with different ET gene carriage profiles. The 
expA gene (red arrow) was located upstream of a retron-type reverse transcriptase. 
Selected genes are labeled as annotated in PATRIC and the same color indicates the same 
gene in each line, except for the 29-002 downstream sequence which is given in the 3’ to 
5’ direction. The downstream region to expA was only captured in isolate 29-002. The 
arrows indicate the direction of the open reading frame of the gene (i.e. 5’ to 3’ direction). 
HKU10-03 is the S. pseudintermedius reference genome. Isolate 2001-08-299-1 is a 
publically available draft genome that carries expA. 
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ExpB 
The mapping findings for expB in the sequenced isolates are summarized in Fig. 
8. There was variation in the expB amino acid sequence in two (12-005 and 30-090) of the 
examined single carriage (speta+siet+expB) and one (29-002) of the dual 
(speta+siet+expA+expB) isolates from the expB reference sequence (AB569087). In these 
isolates, there was an A to G base substitution at nucleotide position 70, resulting in an 
arginine to glycine amino acid substitution at codon position 24. The impact of the Arg-
Gly substitution on the function of expB in these isolates warrants further study. The 
remaining three single carriage and one of the dual carriage isolates had 100% identity to 
the reference sequence. The expB gene is adjacent and upstream of the se-int exotoxin 
gene, fosfomycin resistance protein (fosB) and β-lactam resistance protein (fmtA). There 
was fragmented, incomplete coverage of the expB region in 29-002, but the isolate did 
have some of the same components in this region as observed in the other dual carriage 
isolate 33-100 and the single expB carriage isolates. PHAST queries of the upstream and 
downstream regions to expB did not reveal any components that were similar to known 
phage-related proteins or elements in the database, and a PlasmidFinder query did not 
reveal any plasmid origins of replication in the expB flanking regions. A prophage 
integration site was upstream of se-int in HKU10-03. The proteins annotated as PI-related 
proteins by PATRIC in the two expB configurations (33-100 and 12-005 as examples) 
were analyzed with PAI DB and revealed a potential transposase/phage integrase (32% 
identity with IS1133 transposase) and a MGE with characteristics of a transcriptase in both 
configurations; an uncharacterized PI protein (52% identity with phage-associated protein 
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in SaPIbov2) was identified in isolates with a configuration similar to 33-100. The findings 
suggest that the mobile element protein and the predicted transposase/integrase may be 
important in the carriage and potential horizontal transfer of expB. 
 
Figure 8: Position of expB in isolates with different ET gene carriage profiles.  
The expB gene (gray arrow in blue box) was located upstream of the se-int exotoxin gene. 
The expB region in isolate 29-002 was highly fragmented. Selected genes are labeled as 
annotated in PATRIC and the same color indicates the same gene in each line. The arrows 
indicate the direction of the open reading frame of the gene (i.e. 5’ to 3’ direction). 
HKU10-03 is the S. pseudintermedius reference genome. 
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MLST and virulence gene carriage characteristics 
  The MLST, agr type, and other selected virulence gene carriage findings are 
summarized in Table 4. Nine new MLST were identified (ST755, 762, 765-771). Two of 
the expB isolates, 30-090 and 37-024, carried ack gene allele types (designated MLST 
New1 and New2) that were not recorded in the BIGSdb. All of the isolates had different 
ST and were members of four different CC. For seven of the isolates, the CC was unable 
to be determined, either because the isolate could not be placed in a group (i.e. a singleton), 
possessed a novel allele type, or was in a group where the founder could be determined 
due to paucity of isolates in the group. The agr types encountered were diverse for each 
ET gene carriage profile and included type II (n = 6), IV (4), and III (3) systems. None of 
the isolates carried BacSp222 or genes with > 90% homology to S. aureus SEA, SEB, 
SED, or TSST-1. The absence of carriage of BacSp222 in the small sample set is 
unsurprising as carriage of this bacteriocidin is rare [100]. All of the examined isolates 
carried lukSF-I and se-int, findings that are similar to the almost universal carriage 
mentioned in previous reports [99,109,112]. Two isolates of differing ET gene carriage 
profile carried seccanine (41-073 and 29-002). Previous studies with canine-derived S. 
pseudintermedius isolates have reported a seccanine prevalence of 1.5-5% [112,115]. 
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Table 4: Summary of MLST and selected virulence gene carriage for the 13 S. 
pseudintermedius isolates used for WGS. New 1 and New 2 indicate that the isolates 
contain novel ack gene alleles that were not recorded in the BIGSdb. CC = clonal complex; 
MLST = multi locus sequence type; -- = CC not able to be determined; singleton = single 
isolate in CC group; + and - indicate the presence and absence of the indicated gene, 
respectively. 
ET gene 
profile 
Isolate 
# 
MLST CC 
agr 
type 
lukSF-
I 
seccanine 
se-
int 
BacSp222 
expA 
29-095 765 68 IV + - + - 
30-085 766 singleton II + - + - 
38-056 767 -- III + - + - 
37-029 768 277 II + - + - 
41-073 155 54 IV + + + - 
expB 
12-005 769 singleton III + - + - 
30-090 New1 -- II + - + - 
31-062 257 258 II + - + - 
37-024 New2 -- II + - + - 
39-026 762 singleton III + - + - 
expA + 
expB 
29-002 770 68 II + + + - 
33-100 771 singleton IV + - + - 
speta + 
siet 
19-040 755 54 IV + - + - 
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CHAPTER VI 
MOLECULAR CHARACTERIZATION OF S. AUREUS ISOLATES FROM HORSES 
(2007–2017)  
 
Introduction 
This study is the first to use WGS methods on a large collection of S. aureus 
isolates, including MRSA and MSSA, collected from horses. WGS has been used to 
retrospectively investigate and track emerging outbreaks of MRSA in human hospitals and 
communities [149]. To date, no studies have examined the complete toxin gene carriage 
profiles of equine MSSA and MRSA strains from equine isolates collected in the southern 
US, with most studies examining only equine MRSA in Canada or the Northeast and 
Midwest US [69,70]. The goal of this study was to use WGS to investigate the 
relationships between strain type, toxin gene carriage and antibiotic resistance in 72 S. 
aureus isolates collected from horses and donkeys that presented to the TAMU VMTH 
over a ten-year period to investigate the clonality of S. aureus isolates cultured from equine 
patients and to determine if the carriage of toxin genes and antimicrobial resistance genes 
was similar among isolates.  
Since antimicrobial resistance, often to multiple classes of drugs, is a significant 
problem in community and hospital-acquired strains, we also investigated major genes 
contributing to antimicrobial resistance in S. aureus in the equine isolates. The genes 
responsible for high-level aminoglycoside resistance in S. aureus are aac (6')-Ie/aph (2'') 
(aac6-aph2) and aph (3')-IIIa (aph3-III), and kanamycin/neomycin resistance in 
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staphylococci is mediated by the plasmid-borne kanamycin nucleotidyltransferase gene, 
ant (4')-Ia or aadD [150]. One of the main genes involved in chloramphenicol resistance, 
cat, is carried on the plasmids pC221 and pC223 [151], and trimethoprim-sulfa (TMS) 
drug resistance is mediated by the dfr genes [11]. Efflux pumps encoded by the tet genes 
are major mediators of tetracycline resistance and include the plasmid-borne tetL and tetK 
and the transposon-mediated, chromosomally integrated tetM; the related multidrug efflux 
pump encoded by norA contributes to fluoroquinolone resistance [11].  
While macrolides, such as erythromycin, are not commonly used to treat 
staphylococcal infections, they are widely used to combat other bacterial infections, and 
resistance mediated by the erm, msrA, or mphC genes is common in S. aureus due to 
secondary exposure in mixed infections [11]. While rare compared to resistance in other 
antimicrobial classes, macrolide resistance has been reported in equine-derived 
Staphylococcus spp. isolates [11,151,152], and macrolides are commonly used to treat 
Rhodococcus equi respiratory infections in foals [12]. Treatment with lincosamides, such 
as clindamycin, is typically contraindicated in horses due to the potentially fatal 
enterocolitis complications that arise from their use, but resistance (due to the lincosamide 
nucleotidyltransferase lnu genes) is occasionally reported in animal-derived staphylococci 
[153]. Resistance to spectinomycin and streptomycin is mediated by carriage of spc and 
str, respectively [154].  Mutations in the rpoB gene in MRSA strains can confer resistance 
to rifampicin by altering the ribosomal binding site [11,155]. Fosfomycin is a drug used 
to treat multi-drug resistant (MDR) strains, but resistance mediated by the fosB gene is an 
emerging problem and is often seen in CC8 isolates from horses [156,157]. Resistance to 
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quaternary ammonium compound disinfectants, such as chlorhexidine, mediated by 
qacA/B, qacC, or qacJ is also relatively common S. aureus isolates, particularly of ST1 
lineage [158,159].  High-level mupirocin resistance is mediated by transfer of the plasmid 
carrying mupA, a gene that encodes a version of isoleucyl-tRNA synthetase that cannot be 
bound by mupirocin [11].  
In addition to the three classes of toxins discussed in Chapter II, we also 
investigated carriage of the bacteriophage immune evasion cluster (IEC) genes (sak, scn, 
and chp), which are often carried with SEA and SEP [160], and the ACME which is 
thought to mediate colonization of skin in people [117]. The IEC are phage-encoded 
proteins that integrate into the bacterial genome and function by inhibiting host neutrophil 
chemotaxis, cleaving host defensing proteins, and inhibiting host opsonization by 
blocking the formation of C3b on the surface of the bacterium [160].  
In summary, we investigated whether carriage of toxin genes, 
antimicrobial/disinfectant resistance genes, and other virulence factors were associated 
with ST, agr type, or patient clinical outcome (i.e. survival or death) in the collection. We 
hypothesized that there would be differences in carriage of virulence genes between 
isolates, and these differences would likely be related to the genetic lineage or clonality of 
the isolates. 
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Materials and methods 
Collection demographics 
The collection consisted of 71 S. aureus isolates cultured from 65 horses (Equus 
ferus caballus), six donkeys (Equus africanus asinus), and one mule that presented to the 
Texas A&M University Veterinary Medical Teaching Hospital from July 2007 to January 
2017. One environmental S. aureus specimen collected in 2008 from a procedure area in 
the hospital was also included in the study. All patient isolates were residual diagnostic 
specimens that were collected under the standards of care guidelines for the hospital and 
with written owner consent obtained to retain isolates for research purposes. Fourteen 
horse breeds were represented with American Quarter Horse (n = 29), Thoroughbred (n = 
7), and American Paint (n = 7) horses being the most common breeds encountered. Of the 
six donkeys, three were of unspecified breed, two were miniature, and one was an 
American mammoth donkey. The average age of the equids that contributed isolates in the 
collection was 8.4 years ± 7.6 years (range 1 day to 31 years). The majority of the isolates 
were cultured from mares (n = 35) and geldings (n = 25), with fewer isolates from stallions 
(n = 10) and one isolate recovered from the lung (considered blood/hematogenous isolate) 
of an aborted male, full-term Clydesdale fetus. Culture site locations were diverse and 
included skin (n = 26), respiratory secretions or tissues (15), bones or joint tissues (15), 
blood (6), cornea (5), urine (1), uterus (1), abdominal mass (1), lymph node (1), and 
environmental (1) sources; the majority of the isolates were collected in 2016 (n =16), 
2010 (12), 2014 (12), and 2015 (12) (Fig. 9). Bacterial quantification based on growth in 
the four plate quadrants (i.e. 2+ = growth in 2nd quadrant, etc.) at the time of diagnosis was 
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available for 43 isolates: 1-6 colonies (n = 8), 1+ growth (8), 2+ growth (13), 3+ growth 
(9), 4+ growth (5), and isolated only after broth enrichment (7). The urine isolate (33-029) 
was quantified as 200 cfu/mL. Of the 71 equids, 23 died or were euthanized within 3 
weeks of discharge from hospital, with 20 animals receiving a post-mortem examination.  
  
 
 
 
Antimicrobial susceptibility and mecA testing 
Samples from the patients were processed within 24 hours of collection, and the 
bacteria were speciated as S. aureus based on colony morphology and a combination of 
standard laboratory techniques and/or confirmation with a diagnostic staphylococcal 
speciation PCR using previously described methods [1,132]. Minimum inhibitory 
concentration (MIC) data for selected antimicrobials was available for 51 isolates. A 
commercial assay, using either Vitek (bioMérieux, Durham, NC) or TREK Sensititre 
Figure 9: Distribution of the 72 equine S. aureus isolates by culture site and year 
isolated. The Other category includes abdominal mass, uterine and lymph node cultures. 
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(TREK Diagnostics, Cleveland, OH) MIC plates, was used at time of initial diagnosis to 
determine antimicrobial susceptibility according to the Clinical and Laboratory Standards 
Institute (CLSI) guidelines for MIC testing [132]. As isolates were tested for antimicrobial 
susceptibility as part of patient care, the specific drugs tested varied due to culture site-
dependent appropriateness of the antimicrobial panel. Production of in vitro β-lactamase 
was assessed via nitrocefin test in 46 isolates [161]. All 72 isolates were struck onto LB 
agar containing dissolved mupirocin or vancomycin (Sigma-Aldritch, USA) at a final 
concentration of 8 µg/mL or 3 µg/mL, respectively, with a 96-pin microplate replicator 
(Boekel Scientific, Feasterville, PA, USA) and incubated at 37°C for 24 hours for 
screening of low-level mupirocin and intermediate vancomycin resistance. All isolates 
were screened via PCR for the presence of the mecA cassette at time of initial diagnosis, 
with Staphylococcus aureus subsp. aureus Rosenbach ATCC ® 43300™ and 29213™ 
used as mecA-positive and -negative control strains, respectively. All isolates that carried 
mecA, regardless of the oxacillin resistance results for isolates with MIC data, were 
classified as MR for the analyses. 
 
Bacterial culture and DNA extraction 
Isolates were preserved at -80°C after initial culture in 20% glycerol-infused 
lysogeny broth (LB). Isolates were struck onto LB agar and incubated at 37°C for 24 
hours. Single colonies for each isolate were inoculated into 1 mL of brain-heart-infusion 
broth (BD Diagnostics, Franklin Lakes, NJ, USA) and the isolates were incubated at 37°C 
for 12 hours in an orbital shaker at 200 rpm. The broth cultures were transferred to 
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microcentrifuge tubes and centrifuged at 8,000 rpm (5,510 x g) for 15 min, the supernatant 
was removed, and the pellets were used for DNA extraction. DNA extraction was 
performed with a DNeasy® Blood & Tissue Kit (Qiagen, Germantown, MD, USA) 
according to the manufacturer’s recommendations for Gram-positive bacteria, except 1 µl 
of a solution of 5 mg/mL lysostaphin (L7386; Sigma-Aldritch) derived from 
Staphylococcus staphylolyticus was added to the lysis buffer per isolate. 
 
Library preparation and whole genome sequencing 
The aim for the minimum targeted coverage for the combined runs was the same 
as in Chapter V, approximately 50-fold, and two independent sequencing runs were done 
for the 72 samples. Sequencing libraries were prepared using the Nextera XT library prep 
kit (Illumina, San Diego, CA). DNA was quantified using the Qubit™ 2.0 (Life 
Technologies, Carlsbad, CA) high sensitivity double stranded DNA (dsDNA) assay and 
all samples were normalized to 0.2 ng/µL. Five microliters of normalized DNA (1 ng total 
DNA) was used for library preparation. Libraries were prepared on an epMotion® 5075 
(Eppendorf, Hauppauge, NY) fluid handling robot adapting the Illumina Library 
Preparation Protocol for automation. Prepared libraries were checked with the Qubit™ 2.0 
dsDNA assay to determine concentration and a TapeStation D1000 HS (Agilent 
Technologies, Santa Clara, CA) was used to determine the average fragment size of the 
prepared libraries. All samples were normalized to 4 nM and all 72 samples were pooled 
together for sequencing. The 4 nM pool was diluted to 20 pM and sequenced on the 
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Illumina MiSeq 300 x 300 cycle v3 sequencing kit. All run data and FASTQ files were 
uploaded to BaseSpace (https://basespace.illumina.com/) for downstream analysis.   
 
Genome assembly and annotation 
The online sequencing pipeline offered by the Pathosystems Resource Integration 
Center (PATRIC version 3.4.6; https://www.patricbrc.org) was used to assemble and 
annotate the S. aureus genomes [140]. The Illumina MiSeq paired read libraries for each 
isolate from the two runs were uploaded to PATRIC and de novo assembled using the 
recommended MiSeq assembly strategy parameter. Briefly, this setting uses Velvet with 
hash length 35 and trims with BayesHammer. The resulting contigs were then assembled 
using SPAdes with a k up to 99, and the results were sorted by quality score and combined 
with Assembly RAST [140]. Genome coverage of the combined MiSeq runs was 
estimated by comparing the total nucleotide bases per isolate to the 2.82 Mb S. aureus 
subsp. aureus NCTC 8325 reference genome in GenBank (NC_007795.1). Annotation 
was done using the Rapid Annotation using Subsystem Technology tool kit (RASTtk) on 
the PATRIC pipeline [141].  
 
Strain typing and eBURST analyses 
Due to the propensity for alignment errors to occur in tandem repeat areas of the 
S. aureus spa gene with WGS, the spa sequences were amplified via PCR as previously 
described [60] and the forward and reverse strands were Sanger sequenced (Eton 
Biosciences, San Diego, CA). The spa type for each of the isolates was determined using 
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the tool spaTyper (http://spatyper.fortinbras.us/) on the Sanger sequences and compared 
to the spa sequences in the WGS assemblies; new types were submitted to the Ridom 
SpaServer (http://www.spaserver.ridom.de/) for inclusion in the database. Misalignments 
of the spa gene occurred in 10 of the WGS assemblies, and the spa type recorded for the 
isolates was based on the Sanger sequences. One isolate could not be dru typed via WGS 
and non-amplification of the dru was confirmed via the previously described PCR method 
(ref). Multilocus sequence typing using seven conserved S. aureus genes and rMLST using 
51 non-paralogous ribosomal genes (excluding allele type for rpsN and rpmG as 
recommended for staphylococci) were performed in silico with the assembly files as 
described previously [51,63,76] using the batch query tools on the S. aureus MLST 
(https://pubmlst.org/saureus/) and rMLST (https://pubmlst.org/rmlst/) databases as part of 
the BIGSdb genomics platform [78].  
New MLST arcC allele sequences for three isolates were confirmed with Sanger 
sequencing. New MLST and rMLST allele sequences and types were submitted for 
inclusion in the respective databases (curator- Keith Jolley). The rMLST alleles for rpmA, 
rpmF rpsT, and/or rpsU were missing or misaligned in seven of the WGS assemblies, and 
the respective segments were amplified via PCR with newly designed primers (Table 5) 
and Sanger sequenced (Eton Biosciences) for confirmation of allele type. The missing 
ribosomal genes were added to the WGS assemblies with Geneious R10 (Biomatters 
Limited, Auckland, New Zealand) using the consensus sequences for each gene generated 
from the trimmed forward and reverse Sanger sequenced strands. The MRSA isolates were 
screened via PCR for amplification of the dru segment as previously described [61], and 
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dru type was assigned in silico by querying the mecA cassette sequences for each isolate 
WGS against the online dru repeat and typing database (http://dru-typing.org/site/; 
curator- Richard V. Goering). The SCCmec type was assigned via in silico BLAST query 
using the previously described PCR method for typing cassettes I – VI and assigning 
subtypes [47]. 
 
 
Table 5: PCR primers for amplification of S. aureus ribosomal genes for rMLST. 
PCR reagent concentrations were formulated according to the manufacturer’s 
recommendations (AmpliTaq® DNA polymerase; Thermo-Fisher Scientific). The PCR 
thermal cycler conditions were initial denaturation at 95 °C for 5 min followed by 30 
cycles of 95 °C for 5 min, annealing at 50 °C for 1 min, and extension at 72°C for 1 min, 
followed by a final extension step of 72°C for 7 min. 
 
 
 Minimum spanning trees were generated using PHYLOVIZ [162], and the full 
goeBURST plugin was used to cluster S. aureus ST in the MLST database (as of 
September 2017). Founders of CC were assigned based on the ST that had the greatest 
number of single-locus variants (SLVs; i.e. an isolate that differed from the most STs at 
only a single locus), and the potential founding isolates of S. aureus-associated rMLST 
groups were also predicted in a similar manner. As of 2014, the historic CC1, CC5, CC8, 
Gene Forward primer (5’ → 3’) Reverse primer (5’ → 3’) Amplicon 
size (bp) 
Reference 
rpmA AGGGGCTCTTATGCA
GTTGT  
TATCGTTTGTGCTGG
AGCTT  
666 This study 
rpmF CGACAAGTTGATCCA
AGGCT  
TTGGCGGATGAGGT
ATCCTG  
421 This study 
rpsT AAATTTTGATAAGAT
GAACTCACTTTTAG 
AGATGCTTGTGCGG
AAACTG 
425 This study 
rpsU TTTCACCTCGCCCTC
ACATT 
ACGTTGTTTTAACG
GCTTCACA  
634 This study 
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CC15, and CC97 are now grouped into one large CC in the MLST database [163], with 
ST97 as its potential founder. For comparison purposes with other studies, we have kept 
these CC separate and have retained the conventional founders for each group (i.e. ST1 as 
founder of CC1, etc.). A phylogenetic tree incorporating 50 (the limit for the method) of 
the clinical horse isolates, the S. aureus subsp. aureus NCTC 8325 ST8 reference strain, 
and outgroups Macrococcus caseolyticus JCSC5402, Staphylococcus saprophyticus 
ATCC 15305, and Staphylococcus epidermidis ATCC 12228 was constructed with the 
Phylogenetic Tree Building plugin in PATRIC using the FastTree option and exported to 
the online Interactive Tree of Life (ITOL v.3; http://itol.embl.de/) interface for editing 
[140,164,165]. 
  
Toxin, antimicrobial resistance, and virulence gene queries 
The assembly files and annotated genomes were queried using the standalone 
BLAST+ suite version 2.6.0 (NIH, Bethesda, MD) and BLAST nucleotide and protein 
interface in the PATRIC database, respectively. The publically available bacterial 
antimicrobial resistance gene database Antibiotic Resistance Gene-ANNOTation (ARG-
ANNOT) and the staphylococcal VirulenceFinder 1.5 database files available from the 
Center for Genomic Epidemiology (both current as of March 2017) were used to make the 
database for the BLAST+ queries [145,166]. Nucleotide sequences in GenBank for lukPQ 
(LT671578.1), qacA/B (GU565967.1), qacC (M37889.1), phenol soluble modulins 1-4 
(BK006301.1) and chp (AF285146.1) were also added to the database. A positive hit for 
a gene was defined as a query having at least 96 % identity with and covering at least 90 
% of the length of the database gene reference. The agr type was assigned based on 
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BLAST query using primer sequences from the previously described PCR typing method 
[80]. The IEC type, based on the presence of the sea or sep and scn, sak, or chp genes, was 
assigned in silico via BLAST query using the previously described PCR typing scheme 
[160]: A = sea+sak+chp+scn, B = sak+chp+scn; C = chp+scn, D = sea+sak+scn, E = 
sak+scn, F = sep+sak+chp+scn, G = sep+sak+scn. To ensure that all the toxin and 
virulence genes were detected in the genomes, the raw MiSeq FASTQ files were converted 
to FASTA files with fastq2fasta (TM Software, Inc., Arcadia, CA) and searched with a 
combination of the PCR primer sequences specific for each enterotoxin [167] or IEC [160] 
gene and the previously mentioned BLAST+ VirulenceFinder database to account for 
sequence variation. Potential hits were then queried against the NCBI database using the 
online BLAST-n interface; a cut-off of > 90% identity to a known toxin or virulence gene 
sequence cataloged in GenBank was used to identify the genes. Potential regions 
containing prophages were analyzed with PHAST [142]. 
 
Results and discussion 
Assembly findings 
The average coverage achieved over the combined MiSeq runs for all isolates was 
64-fold (range, 41 to 90-fold), with removal of one outlier (60-073) that had 174-fold 
coverage. Nine isolates had coverage estimates lower than the benchmark goal of ≥ 50-
fold. While overall genome coverage was high, coverage of some areas containing highly 
repetitive regions, such as the spa gene and the region flanking the egc and seh, was low 
in 10 isolates, resulting in fragmentation of genes. In these instances, either Sanger 
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sequencing or conversion and BLAST query of the reads for each isolate (as outlined in 
the methods) was performed to accurately assess type and gene carriage. 
 
Clinical and post-mortem findings 
The most common clinical findings reported for the equids were subcutaneous 
abscesses/cellulitis or dermatitis (n = 17), osteomyelitis and/or joint infections (15), 
pleuropneumonia (6), and corneal ulcers (5). In the dermatitis cases, most of the lesions 
were located on the limbs (n = 10). Two horses had documented recent travel history from 
Canada (Horse 33) and France (Horse 64). Two horses were cultured (penile and clitoral 
fossa swabs) as part of a breeding soundness exam. Nine of the cases involved infection 
of surgical sites, two involving infection of joint implants and seven involving skin 
infections related to incisional dehiscence. Cytologic examination of fluid or tissue 
aspirates was performed by a clinical pathologist in 22 of the cases involving joint (n = 8), 
eye (5), respiratory (5), abdominal (2), skin (1), and urinary (1) infections. Neutrophilic to 
suppurative inflammation was observed in the tissues of 19 cases and, within that subset, 
coccoid bacteria were seen in 10 cases. In the majority of the cases ending in death or 
euthanasia (65%; 15/23), the reason could be attributed to bacterial infections in which S. 
aureus was cultured. Of the 20 animals receiving a full necropsy, the gross findings 
included bronchopneumonia (n = 6; Fig. 10A), chronic joint infections (5), wounds or skin 
abscesses (5), corneal ulcers (2), a nasal mass (1), and abdominal abscesses (1; Fig. 10B). 
In one case (Horse 68), death resulted from severe, secondary bacterial infection at sites 
of previous erythema multiforme (Fig. 10C). Histologic findings included 
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necrosuppurative bronchopneumonia with Gram-positive cocci (Fig. 10D and inset), 
synovitis and tenosynovitis, and subcutaneous or intraabdominal abscesses.  
 
 
 
 
 
Figure 10: Gross and histologic lesions attributed to S. aureus infection in horses.  
A- Horse 33, sectioned lung, necrosuppurative bronchopneumonia. 
B- Horse 52, diaphragm and liver, suppurative peritonitis and hepatitis with adhesions. 
C- Donkey 68, flank, multifocal ulcerative and suppurative dermatitis. 
D- Horse 33, lung, necrosuppurative pneumonia with large clusters of bacteria (H&E); 
inset- Gram-positive cocci in lesion (Hucker-Twort Gram stain). 
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Typing characteristics 
Eighteen distinct ST were represented, with ST1 (n = 18), ST133 (11), ST8 (9), 
and ST97 (9) most frequently encountered. Three new MLST (4214, 4215, and 4277) were 
identified due to single point mutations in the arcC gene. The most common spa types 
were t127 (n = 13), t1294 (6), t064 (6), and t008 (5). Two new spa repeats were discovered 
r667 (AAAGAAGATCGCAACAAGCCTGGT) and r748 
(AAAGGAGACAACAAAAAACCTGGC); six new spa types were discovered in MS 
isolates: t17107 (repeats 03-16-21-149-23-13-17-149-23-24), t17108 (03-16-21-17-23-
13-17), t17109 (03-16-21-17-23-13-17-17-17-23-667), t17110 (03-13-17-17-23-24), 
t17118 (15-16-34-34-33-13), and t17146 (15-12-16-748-16-02-25-17-24-24), 
representing one isolate each. The ST and spa type combinations observed are illustrated 
in Fig. 11. The most common ST- spa type pairings were ST1- t127 (n =13), ST816- t1294 
(6), ST8- t008 (5), ST97- t2112 (4), and ST8- t064 (4). The two horses with documented 
travel outside the US cultured ST1-t127 MSSA, a major ST circulating in human 
communities in Canada and the northern US [136] and one of the most predominate equine 
MSSA strains in Denmark [37]. The overall prevalence of MSSA in the collection was 
81%, and the majority of the MSSA isolates were ST1-t127 (n =13), ST816-t1294 (6), 
ST97-t2112 (4), or ST133-t1166 (3). ST1, ST133, and ST97 lineages are commonly 
cultured from livestock in Canada, Europe, and Africa [37,96,120,168,169]. The spa type 
t1294 has been described in one study of equine isolates in Denmark [170], but it has not 
been linked to ST816 or been described in the US before. The isolates cultured from the 
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lesions in the equids illustrated previously had the following typing characteristics: Horse 
33- ST1-t127-57195; Horse 52- ST4277-t701-57185; Donkey 68- ST133-t2420-54226. 
 
 
 
 
The overall prevalence of MRSA (defined as mecA-positive isolates) in our study 
was 19%. Of the 14 mecA-positive isolates, there were 64% ST8 (9/14), 14% ST612 
(2/14), 14% ST398 (2/14), and 7% ST5 (1/14). SCCmec types observed included IVa (n 
= 7), IVd (6), and IIa (1). Four dru types were identified: dt9g (n = 5), dt10a (4), dt10q 
(2), and dt7d (2). The ST5 isolate (38-086) was untypable because it contained a deletion 
in the dru region that was confirmed by absence of a dru amplicon via the conventional 
PCR method. There were two distinct groups of ST8 MRSA: five isolates characterized 
by SCCmec type IVa, spa type t008, dru type dt9g, and four isolates having SCCmec IVd, 
spa t064, and dru dt10a. Most of the equine MRSA cases in our study were attributable to 
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Figure 11: Distribution of ST and spa type pairings for the 72 equine S. aureus 
isolates. 
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the USA 300 clone (ST8-IV-t008; PVL-positive) [117], a clone implicated in the majority 
of outbreaks of CA-MRSA in the US, and the Canadian USA500 clone (ST8-IV-t064; 
PVL-negative) [169]. The high percentage of ST8-associated MRSA is similar to cases in 
veterinary hospitals in the northeastern US, Ohio and Canada attributable to USA500 and 
to infections at French stud farms [34,69,70,169]. However, in contrast to findings in 
European horses [34,120,171] where the originally porcine-associated ST398 is a 
predominant clone, only two of the MRSA isolates in our study were ST398. Methicillin-
resistant strains were collected from two of the horses that died, but only one was infected 
with a MR strain (51-045) that directly contributed to death. Of the nine surgical site 
infections, three were attributed to MR strains: a tarsal incision line infection caused by a 
ST8-IVd-t008-dt9g isolate, a celiotomy incisional infection caused by a ST612-IVd-t064-
dt7d isolate, and a paralumbar fossa incisional infection caused by a ST398-IVa-t011-
dt10q isolate. A full minimum spanning tree based on MLST was drawn for the mecA 
positive and negative isolates (Fig. 12) using the goeBURST algorithm in PHYLOViZ, 
and a summary of the findings for the 14 mecA-positive isolates is given in Table 6 . 
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Figure 12: Full minimum spanning tree for the 72 equine S. aureus isolates. The red 
shading indicates the proportion of MRSP isolates for the indicated ST and the blue 
indicates MSSP. The size of the spheres reflects the number of isolates of that type, and 
the numbers on the connecting lines indicate % similarity in increments of 0.5% (i.e. 1 = 
99 to 99.5% similarity; 2 = 98.5 to 99% similarity, etc.). 
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      Table 6: Clinical and strain typing characteristics of the 14 mecA-positive S. aureus isolates.  
      *phenotypically methicillin-sensitive isolate; asurgical site infection; CC = clonal complex; Enviro = environmental  
      isolate; NA = not amplifiable due to dru deletion event. 
 
Equid 
ID 
Isolate 
ID 
Isolation 
Year 
Age 
(yrs) 
Sex Breed Infection site Outcome MLST CC 
SCCmec 
type 
spa 
type 
dru 
type 
rMLST 
Enviro 11-028 2008 -- -- -- -- -- 8 8 IVd t064 dt10a 53899 
2 11-038 2008 14 Mare Quarter Horse Skin Survived 8 8 IVd t064 dt10a 53899 
6 20-093 2010 18 Gelding Quarter Horse Respiratory Survived 8 8 IVa t008 dt9g 4320 
15 29-021 2010 30 Gelding Mixed Breed Respiratory Survived 8 8 IVa t008 dt9g 4320 
16 29-031 2010 4 Mare Quarter Horse Cornea Died 8 8 IVa t008 dt9g 57201 
19 31-073 2011 10 Gelding Mixed Breed Skina Survived 8 8 IVa t008 dt9g 4320 
27 38-086 2012 14 Gelding Quarter Horse Cornea Survived 5 5 IIa t002 NA 4326 
28 40-086 2012 6 Mare Quarter Horse Bone/Joint Survived 8 8 IVa t008 dt9g 4320 
37 49-069 2014 0.2 Mare Donkey Bone/Joint Survived 398 398 IVa t011 dt10q 4340 
41 51-045 2014 0.08 Stallion Donkey Respiratory Died 8 8 IVd t064 dt10a 53899 
42 51-058 2014 6 Gelding 
American 
Paint 
Skin Survived 8 8 IVd t064 dt10a 54220 
46 56-089 2015 16 Mare Quarter Horse Skina Survived 398 398 IVa t011 dt10q 57692 
51 60-070* 2015 31 Mare Arabian Respiratory Survived 612 8 IVd t064 dt7d 54222 
53 61-017 2015 3 Gelding Thoroughbred Skina Survived 612 8 IVd t064 dt7d 54222 
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Nine CC were represented and groupings are represented in the phylogenetic tree 
(Fig. 13): CC1 (n = 19), CC133 (12), CC8 (12), CC97 (9), CC5 (5), CC398 (3), CC15 (1), 
CC45 (1), and CC30 (1). Two ST (1660 and 4215) could not be assigned to CC, and ST816 
was a singleton. All of the CC8 isolates were MRSA, and CC8 is one of the most common 
complexes associated with MRSA in horses [157]. The CC133 and CC97 groups are 
typically associated with livestock [96,104], and CC15 has rarely been cultured from 
donkeys in Tunisia [96]. The CC5 (USA100), CC30 (USA200), and CC45 (USA600) 
strains are typically associated with human infections and are the most common CC 
contributing to blood infections and endocarditis in people [53]. Mucosal infections in 
people are predominately caused by CC30, and CC45 is a frequent colonizer of human 
skin in the US and northern Europe [53]. Forty-nine rMLST types were observed, and 41 
new types were identified in this study. The most common rMLST were 4390 (n = 8), 
4320 (4), 54212 (4), 57189 (4), and 53899 (3). The 4390 (ST1), 4320 (ST8), 6128 
(ST816), and 4340 (ST398) types were identical to the rMLST of European strains 
deposited in BIGSdb. The new rMLST 57189 (ST816), 53899 (ST8), 54212 (ST97), 
54222 (ST612), and 57200 (ST133) occurred in multiple isolates in the collection and may 
represent substrains that developed in the US.  
 89 
 
 
Figure 13: Phylogenetic tree of 50 of the equine S. aureus clinical specimens. The 
associated CC are labeled at right. The numbers on the nodes are the bootstrap values. 
Branch lengths have been ignored. 
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Toxin and virulence gene carriage 
Exfoliative and membrane damaging toxins 
None of the isolates carried ETA, ETB, or ETD. Alpha-hemolysin was carried by 
92% (66/72) of the isolates, and β-hemolysin was present in 97% (70/72) of the isolates. 
All isolates carried aureolysin and the γ-hemolysin HlgA, HlgB, and HlgC components. 
None of the isolates carried lukMF’ or any of the EDIN genes. Panton-Valentine 
leucocidin was only found in the five ST8-IVa-t008-dt9g isolates, USA300, which is a 
human CA-MRSA strain [104]. The majority of the isolates carried lukPQ (66%; 48/73) 
and carriage was associated with presence of the strain 3711 prophage (99% identity to 
reference LT671578.1). Interestingly, all of the lukPQ-positive isolates were MSSA, and 
the CC traditionally associated with human infections, such as CC8, 15, and 30 [53], were 
lukPQ-negative. While most of the lukPQ-positive isolates also harbored lukED (81%; 
58/72), none of the PVL-positive isolates also carried lukPQ. This is the first report of 
lukPQ carriage in S. aureus isolates from the US. In the paper first describing lukPQ [91], 
the genes were found in 15% of 87 isolates tested from the Netherlands, Italy, and 
Portugal, and demonstrated lukPQ carriage in ST1, ST133, ST398, and ST1660 isolates 
from horses. However, lukPQ was not found in a 26-isolate MRSA subset used in a 
previous study from The Ohio State University [69], and the ST816, ST6, and ST97 have 
not been described to carry lukPQ. The authors did not mention the methicillin resistance 
status of the isolates they examined in the study, but as only MRSA was reported in the 
Ohio study, most of the isolates used in the initial lukPQ prevalence study were likely also 
MRSA. Given that we did not observe any lukPQ-positive MRSA isolates in our 
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collection, the higher prevalence of lukPQ in our study with US isolates is likely due to 
also screening MSSA or potential differences amongst US vs. European MRSA S. aureus 
isolates. Carriage of lukAB was also common (66%; 48/72), but all of the lukAB-positive 
isolates in the collection also carried lukPQ. None of the isolates carried the four phenol 
soluble modulin genes; however, one isolate (66-100) carried a gene with 97% identity to 
psmA3.  
 
Superantigens 
Many of the isolates carried enterotoxin or enterotoxin-like genes, including sea 
(n = 8), seb (4), sec2 variant (6), sed (1), tsst-1 (7), seg (9), seh (18), sei (11), sej (1), sel-
k (4), sel-l (6), sel-m (11), sel-n (11), sel-o (11), sel-p (1), sel-q (4), ser (1), sel-u (11), and 
sel-x (68).  Carriage of multiple enterotoxins and SEl in a single isolate was common, with 
96% (69/72) of isolates carrying at least one enterotoxin or SEl gene. None of the ST398 
isolates carried enterotoxin genes, a finding that is similar to other prevalence reports in 
Europe that evaluated enterotoxin carriage [120]. Sel-x was the most common enterotoxin 
gene encountered, occurring in 94% of the isolates, and the ubiquitous carriage in our 
study is similar to previous reports [106]. Enterotoxin H was carried by all of the ST1 
isolates and was not observed in other types. Previous studies have reported 100% 
prevalence of seh in ST1 isolates [96,104]. Some of the CC8 MRSA isolates carried sea, 
seb, sel-k, sel-q, and sel-x. The K+Q+X enterotoxin combination is one of the most 
common reported for USA300/CC8 isolates [53]. While most isolates carried two or fewer 
toxins genes, the six isolates belonging to ST816-t1294 and one ST5-t002 isolate carried 
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10 toxin genes. The toxin combinations in relation to ST are illustrated in Fig. 14. All of 
the ST816 isolates carried sea, sec2, sel-l, tsst-1 and the egc2 (composed of seg, sei, sel-
m, sel-n, sel-o, and sel-u), and the tsst-1 amino acid sequences were identical. The region 
containing tsst-1 was different in the ST816 isolates when compared to the ST1 tsst-1-
positive isolate (57-034). In ST816, tsst-1 was carried on a prophage with sel-l and two 
genes similar to sec2, whereas carriage of these genes was not observed in 57-034. An 
intact prophage sequence was found in ST816 isolate 58-006 via PHAST analysis that had 
94% identity to the S. aureus Φ282 prophage (KT809368.1), but covered only 51% of this 
reference sequence. The tsst-1 sequence in 58-006 had 95% identity to the S. aureus N315 
reference sequence (NC_007795.1) and 97% identity to the 57-034 tsst-1. The ST816 
prophage likely carries a tsst-1 variant that is common in ST816 isolates. The CC5 MRSA 
isolate (38-086) carried a plasmid encoding sed and ser in addition to egc2 as is commonly 
observed in CC5/USA100 isolates [53,104]. 
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  Figure 14: Enterotoxin and enterotoxin-like gene carriage combinations vs. ST. 
 
 
Other virulence genes 
The majority of the isolates had agr type I (57%; 41/72) or III (26%; 19/72) 
systems with fewer having type II (15%; 11/72) or IV (1%; 1/72). In a study of S. aureus 
isolates collected from donkeys in Tunisia, the most common agr represented were also 
types I and III [96]. All of the ST8 isolates carried the ACME. Eleven of the isolates 
carried IEC genes with the following IEC and ST pairings observed: A in ST30 (n =1); B 
in ST8 (5), ST5 (2), ST398 (2), ST188 (1), and ST45 (1); C in ST582 (1); D in ST8 (1); 
and G in ST1181 (1). Types B and D are the most common IEC types encountered in 
isolates with type I agr systems, and type A is commonly found in isolates with type III 
agr systems [160]. The lack of the sak gene in the ST582/CC15 isolate is similar to 
previous reports in this lineage [104]. 
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Antimicrobial MIC and resistance gene carriage 
MIC data 
The majority (68%; 49/72) of the isolates were tested via commercial MIC plate 
assay at time of diagnosis against panels of commonly used antimicrobial drugs. 
Antimicrobial drugs tested included: gentamicin (n = 49 isolates tested), ampicillin (47), 
ceftiofur (47), chloramphenicol (47), enrofloxacin (47), tetracycline (47), 
trimethoprim/sulfamethoxazole (TMS; 47), penicillin (46), oxacillin (45), amikacin (36), 
doxycycline (36), cefazolin (34), rifampin (34), ticarcillin with clavulanic acid (34), 
ceftazidime (33), and erythromycin (30). The sensitivities for selected antimicrobials are 
given in Fig. 15. Of the 49 isolates with plate MIC data, most were resistant to the β-
lactam drugs ampicillin (51%; 24/47), and penicillin (48%; 22/46) due to in vitro 
production of β-lactamase. Fifteen of the isolates were designated as resistant to β-lactams 
based on production of β-lactamase in the nitrocefin test. Intermediate or full resistance to 
ceftiofur (45%; 21/47), tetracycline (34%; 16/47), and gentamicin (31%; 15/49) was also 
prevalent. Resistance to rifampin (12%; 4/34), enrofloxacin (7/47; 15%), chloramphenicol 
(19%; 9/47), and doxycycline (19%; 7/36) was uncommon. The 96-pin plate assays for 
intermediate vancomycin and low-grade mupirocin resistance revealed seven 
intermediately (4 µg/mL) vancomycin resistant isolates and one mupirocin resistant 
isolate (17-021) in the collection.  The high level of resistance to β-lactam drugs and 
tetraclycine in the isolates was similar to previous reports in S. aureus from horses in 
Canada and Europe [34,172]. However, the percentage of gentamicin, TMS, and rifampin 
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resistant isolates in the collection is higher than the zero resistance prevalence observed 
in one report from Canada and lower than reports from French stud farms [34,172]. 
  
 
Antimicrobial resistance gene carriage 
The antimicrobial resistance genes carried by the equine isolates were diverse. The 
β-lactamase encoding blaZ gene was present in 27 isolates (38%), including 11 of the 14 
mecA-positive isolates. Of the 24 penicillin-resistant isolates identified in the MIC plate 
26
23
27
25
26
38
29
40
25
34
35
22
30
31
24
39
1
1
8
4
2
1
1
2
0
9
24
7
7
13
5
5
6
4
13
10
24
4
14
10
8
Amikacin
Ampicillin
Cefazolin
Ceftazidime
Ceftiofur
Chloramphenicol
Doxycycline
Enrofloxacin
Erythromycin
Gentamicin
Oxacillin
Penicillin
Rifampin
Tetracycline
Ticarcillin with CA
TMS
Sensitive Intermediate Resistant
Figure 15: Antimicrobial susceptibilities for selected drugs for 49 S. aureus 
isolates as determined through commercial MIC plate assay. CA = clavulanic 
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assay or via nitrocefin test, 15 carried blaZ. One isolate (17-036) carried blaZ but was 
sensitive to penicillin, and one resistant isolate (17-021) did not carry blaZ. The majority 
(15/16) of the resistant isolates with penicillin MIC data (Fig. 16) carried blaZ, but eight 
isolates deemed resistant by the nitrocefin test did not carry blaZ. This discrepancy is most 
likely due to false-positives on the nitrocefin test, which have been reported with animal-
derived S. aureus isolates [161].  Distribution of MR and MS isolates between culture sites 
was similar (Fig. 17). None of the isolates carried high-level vancomycin resistance genes 
(i.e. vanA). Nine of the 10 MRSA isolates evaluated by MIC plate assay were 
phenotypically resistant to oxacillin and carried mecA, while one isolate (60-070) was 
phenotypically oxacillin sensitive but was mecA-positive. This phenotypically oxacillin 
sensitive isolate was a ST612-IVd-t064-dt7d-54222 and had identical typing 
characteristics to the MRSA isolate 61-017 from Horse 51 that was being treated for a 
surgical site infection. Although one report has indicated a plasmid carrying a non-
functional version of the β-lactamase regulatory gene BlaR1 is responsible for mecA 
repression in SCCmec type IV isolates (which have non-functional mecA-regulatory 
genes) [173], no deletion in BlaR1 similar to that described in the report could be found 
in  60-070. However when the BlaR1 sequence in 60-70 was compared MRSA 61-017, 
60-70 did have an Arg-23-Lys substitution near the N-terminus in a similar area to the 
reported deletion. The significance of this mutation on BlaR1 functionality in 60-070 
would require further study.  
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 Figure 17: Distribution of the 72 S. aureus isolates by mecA positivity and culture 
site. MR = mecA-positive, MS = mecA-negative. 
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Aminoglycoside resistance genes were commonly encountered (39%; 28/72) and 
included: single carriage of aac6-aph2 (n = 9), dual carriage of aac6-aph2 and aph3-III 
(2), single carriage of aph3-III (5), single carriage of aadD (2), and dual carriage of aadD 
and aac6-aph2 (10). All of the gentamicin intermediately resistant and -resistant isolates 
identified on MIC plate assay carried aminoglycoside resistance genes. The single carriage 
aadD isolates were ST5, which is prevalent in CC5 isolates [104]. The aminoglycoside 
resistance genes were carried mostly by CC1, CC5, CC8, CC15, CC97, and CC398 
isolates. This is similar to the distribution reported for human ST1 [159] and livestock 
ST398 [154] isolates in Ireland, porcine ST97 isolates in Italy, and CC8 and CC5 human 
isolates worldwide [104]. The only chloramphenicol resistance gene encountered in the 
collection was chloramphenicol acetyltransferase encoded on the pC221 plasmid (n = 7) 
carried by ST8 (n = 3), ST1 (1), ST1660 (1), ST816 (1), and ST612 (1) isolates, which is 
not commonly reported in these ST; all of the chloramphenicol-resistant isolates 
determined by MIC carried the pC221 plasmid. 
The tetracycline resistance genes tetK, tetL, and tetM were detected in eight, nine, 
and nine isolates, respectively; dual carriage was also observed: tetK and tetL (n = 1) and 
tetK and tetM (1). Presence of the norA-encoded drug efflux pump was common (65%; 
47/72). Based in the MIC data, the TMS resistance gene, dfrK, was found only in 
phenotypically TMS-sensitive isolates. The TMS resistance genes were commonly (38%; 
27/72) observed: dfrC (n = 11; ST1, ST8, and ST612), dfrG (6; ST1, ST97, ST133, ST398, 
and ST1660), and dfrK (10; ST1 and ST398). Animal-derived S. aureus isolates frequently 
carry dfrK [154]. The dfrK-encoded protein sequence in the isolates which also carried 
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tetL had only 96% identity with the dfrK reference sequence in the ARG-ANNOT 
database, suggesting that there may be functional differences between the proteins. 
Carriage of tetL was linked with dfrK in the ST1-t127 isolates due to carriage on the same 
plasmid, but Tn559-mediated single carriage of dfrK was also observed in the two ST398-
MRSA-IVa isolates as has been previously described in porcine isolates from Germany 
[174]. In one isolate, 26-006, the dfrK gene was missing from the tetL plasmid, most likely 
due to a plasmid recombination event, but the isolate also carried dfrC which conferred 
high-level TMS resistance.  
Macrolide resistance genes were observed in ten isolates (14%): ermA (n = 2; ST5), 
ermC (1; ST8), msrA (1; ST582), or dual carriage of msrA and mphC (5; ST8 or ST97). 
All of the erythromycin-resistant isolates identified on MIC plate assay carried resistance 
genes. Isolate 17-036 carried msrA and mphC but was phenotypically erythromycin-
sensitive; there were no mutations in msrA or mphC in 17-036. Equine CC8 isolates have 
been reported to carry ermC [157,169], and dual carriage of msrC and mphC has been 
reported in human SCCmec type IV isolates in Japan [123]. One isolate (17-021) cultured 
from pleural fluid in Horse 3 carried the lnuA gene imparting lincosamide resistance and 
also carried the mupA high-level mupirocin resistance plasmid; this case represents the 
first report of these genes in an equine-derived isolate. Interestingly, none of the horses 
that cultured macrolide-resistant isolates were being treated with a macrolide 
antimicrobial drug or mupirocin while in the hospital and use of clindamycin or other 
lincosamides is contraindicated in horses. 
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Carriage of spectinomycin (spc) and streptomycin (str) resistance genes was rare 
with two ST5 isolates carrying spc and three ST8-PVL+ isolates carrying str. Thirty 
isolates (42%) carried plasmids encoding the fosfomycin-resistance gene, fosB, with 40% 
(12/30) of these isolates also carrying mecA. All of the CC5, CC8, CC15, CC30, and 
CC133 isolates in the collection carried fosB, and the gene was not carried by isolates in 
the other observed CC. This fosB prevalence rate is similar to previous reports with CC5, 
CC30, and CC133 isolates of human and animal origin [156,175]. The four rifampin 
resistant isolates identified by MIC plate assay were all MR and did have mutations in the 
rpoB gene associated with phenotypic resistance in S. aureus or E. coli [155]: Asp-471-
Val, Asp-471-Asn, and His-471-Asn; with an additional three isolates identified in the 
collection with identical mutations that would most likely confer rifampin resistance. Nine 
isolates (13%) carried the quaternary ammonium compound resistance genes qacA/B (all 
ST1-t127) and four isolates (6%) carried qacC (ST5, ST8, and ST1660). Carriage of 
qacA/B genes is prevalent in ST1-t127 isolates [159] and qacC has been rarely detected in 
porcine ST97 isolates [168]. 
 
Conclusions 
 The overall prevalence of MRSA in our collection was 19%, and one ST612/CC8 
mecA-positive but phenotypically oxacillin sensitive isolate was found in the collection. 
The predominant MRSA clones were the CA-MRSA USA 300 clone (ST8-IV-t008; PVL-
positive) and the Canadian USA500 clone (ST8-IV-t064; PVL-negative), with most of the 
isolates coming from skin and respiratory tissues. The most common MSSA CC were 
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ST1, CC133, and CC97, and the most common ST-spa type was ST1-t127. New spa types 
(n = 6), MLST (3), and rMLST (41) were discovered in this study. No ET genes were 
identified in the WGS of the equine isolates. The novel purported equine adapted 
leucocidin, LukPQ, was found in 66% of the isolates, and all of the positive isolates were 
MSSA. This is the first report of lukPQ carriage in S. aureus isolates cultured outside of 
Europe. Carriage of sel-x was most common, followed by seh+sel-x in the ST1 isolates. 
All of the ST816 isolates carried a prophage that encoded sea, sec2, sel-l and a novel form 
of tsst-1. Carriage of the IEC was occasionally observed (11%) with type B being most 
common. Most of the isolates were resistant to β-lactam antimicrobials, and resistance to 
ceftiofur (45%; 21/47), tetracycline (34%; 16/47), and gentamicin (31%; 15/49) was also 
prevalent. The antimicrobial resistance genes norA, fosB, blaZ, aac6-aph2 and aadD were 
commonly carried by the isolates. The quaternary ammonium compound resistance genes 
qacA/B and qacC were carried by 18% of the isolates and carriage was most common in 
ST1-t127 isolates. One ST5 isolate (17-021) collected from the pleural fluid of an 
American Paint horse stallion was mupirocin-resistant (mupA) and carried the lincosamide 
resistance gene lnuA, the first report of these resistance genes in an equine-derived isolate. 
The association of MSSA with the majority of the equine infections, most cultured in 
significant amounts with cytologic or histopathologic confirmation, indicates that MSSA 
can be pathogenic in horses. The diverse array of toxin and antimicrobial resistance genes 
found in the equine MSSA isolates also could contribute to patient morbidity, and the 
MSSA isolates could serve as reservoirs for transfer of toxin or resistance genes between 
staphylococci of similar lineage.  
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CONCLUSIONS 
 Staphylococcus spp. are important causes of skin and systemic infections in 
people, dogs, and horses. Methicillin-resistant S. aureus and MRSP infections are 
common in humans and animals. In dogs, S. pseudintermedius is the most common cause 
of pyoderma, and MRSP is a significant contributor to soft tissue infections in dogs. 
Horses colonized with S. aureus can be asymptomatic carriers, but methicillin sensitive 
and MRSA infections have been associated with significant morbidity and mortality in 
horses and bacteria can be transferred between humans and horses. Staphylococcus aureus 
ET genes are associated with blistering skin lesions, and four purported exfoliative toxin 
genes have been reported in S. pseudintermedius: speta, siet, expA, and expB. Few studies 
have determined the prevalence of S. pseudintermedius ET genes in a large collection of 
canine isolates, and it is unknown what conditions facilitate native induction of SIET, 
EXPA, or EXPB, or if dogs produce antibodies to S. pseudintermedius ET. There has also 
been limited study of MSSA infections in horses and previous studies have not examined 
the complete toxin gene carriage profiles of equine MSSA and MRSA strains collected in 
the southern US. There were four aims of this study, and the findings are summarized 
below. 
 
AIM 1: Determine the prevalence of exfoliative toxin (ET) gene carriage in 
Staphylococcus pseudintermedius isolated from dogs. Determine if ET gene carriage 
is correlated to inflammation severity in canine skin biopsies. The prevalence of speta, 
siet, expA, and expB in a collection of 500 clinical isolates from healthy and diseased dogs 
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was 100, 99, 13, and 16%, respectively. The observed ET gene combinations were speta 
alone (0.6%; 3/500), speta+siet (71%; 357/500), speta+siet+expA (12%; 60/500), 
speta+siet+expB (15%; 73/500), and speta+siet+expA+expB (1.4%; 7/500). The expA 
and expB genes were always carried concurrently with siet. There were 159 methicillin-
resistant (MR) S. pseudintermedius isolates; 147 in the diseased dog group and 12 in the 
healthy dog group. The overall MRSP prevalence in the collection was 32%, and the most 
common SCCmec, spa, and dru type combinations were V+t06+dt11a. There was no 
correlation between methicillin resistance status or specific typing characteristics and 
carriage of expA or expB. A higher proportion of the dogs with pyoderma cultured expA -
positive isolates when compared to healthy and diseased dogs. The inflammation severity 
scores of the 25 paired biopsies were correlated to the ET carriage profile of the associated 
bacterial isolates (P = 0.0002; FET). The speta+siet profile was less likely to be associated 
with mild inflammation (P = 0.0001; two-tailed FET), and speta+siet+expA and 
speta+siet+expB were more likely to be associated with mild inflammation (P = 0.0333 
and 0.0162, respectively; two-tailed FET) when compared to other severity categories. 
However, the inflammation scoring study should be repeated with a larger sample size, 
preferably with bacterial culture directly from the collected skin biopsies, to determine if 
there were biases in our collection. 
 
AIM 2: Induce native expression of the EXPA and EXPB toxin proteins in 
bacterial isolates in vitro. Determine if dogs with and without a history of pyoderma 
or culture of S. pseudintermedius produce antibodies to the ET expA and expB. Native 
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induction of EXPA and EXPB was achieved thorough incubation of liquid cultures with 
10% CO2, and both proteins were excreted in the culture supernatant. Expression of EXPB 
and EXPA was observed for the single and dual carriage isolates with bands that 
corresponded to the predicted sizes for each of the proteins. SIET was only labeled in the 
synthetic peptide controls on nitrocellulose dot blot and in the recombinant SIET+GFP 
protein, and native expression of SIET was not observed in the tested S. pseudintermedius 
samples. Sera from the pyoderma/exposed and control dog groups contained antibodies to 
purified EXPA and EXPB, with antibodies in the pyoderma/exposed group also binding 
to a band of the approximate size of the recombinant SIET+GFP from Set 1 as well as 
multiple proteins in the E. coli bacterial lysate. 
 
AIM 3: Perform whole genome sequencing (Illumina MiSeq and Oxford 
Nanopore) on select Staphylococcus pseudintermedius isolates carrying specific ET 
genes to map the positions of the ET genes within the chromosome and determine if 
ET genes are integrated on mobile genetic elements (MGE). Whole genome 
sequencing was performed on a subset of 13 S. pseudintermedius isolates. In the eight 
isolates that carried expA, the ET gene was consistently carried adjacent to a reverse 
transcriptase (Group II intron) that is purported to facilitate horizontal transfer of genes in 
other bacterial species. The expB gene was also adjacent to mobile element proteins that 
may facilitate horizontal transfer of the gene, but the region upstream to expB was variable 
between the examined isolates. The MLST, agr, and spa types were different amongst the 
13 sequenced isolates. Additional sequencing is needed to bridge the gap in the expA 
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region to determine if the upstream and downstream are similar among the isolates. 
Further study is needed to determine if the regions flanking the expB gene influence 
expression of the toxin, and to test whether expA and expB can be horizontally transferred 
between isolates of a similar genetic background (i.e. strain type). 
 
AIM 4: Perform whole genome sequencing (Illumina MiSeq) on 
Staphylococcus aureus isolates from horses admitted to the Veterinary Medical 
Teaching Hospital.  Determine the prevalence of toxin gene carriage in the isolates 
and if there are correlations between toxin gene carriage, patient demographics, 
infection site, or methicillin resistance status. The MRSA prevalence in the collection 
of 71 clinical isolates from horses and donkeys was 19%, with most being clonal complex 
8. The predominant MRSA clones were the CA-MRSA USA 300 clone (ST8-IV-t008; 
PVL-positive) and the Canadian USA500 clone (ST8-IV-t064; PVL-negative), with most 
of the isolates coming from skin and respiratory tissues. The most common MSSA CC 
were ST1, CC133, and CC97, and the most common ST-spa type was ST1-t127. New S. 
aureus spa types (n = 6), MLST (3), and rMLST (41) were discovered in this study. No 
ET genes were identified, and the ST816 isolates carried a prophage encoded variant of 
toxic shock syndrome toxin not previously characterized in isolates from horses. Further 
characterization of the ST816 TSST-1 carrying prophage is needed to determine if the 
variant is equine-adapted and produces similar effects to previously described TSST-1 
variants in an animal model. The novel purported equine adapted leucocidin, LukPQ, was 
found in 66% of all isolates, the first instance of carriage outside of Europe. Carriage of 
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lukPQ only occurred in the MSSA isolates in our collection. The antimicrobial resistance 
genes norA, fosB, blaZ, aac6-aph2 and aadD were commonly carried by the isolates. The 
quaternary ammonium compound resistance genes qacA/B and qacC were carried by 18% 
of the isolates and carriage was most common in ST1-t127 isolates. One ST5 isolate (17-
021) was mupirocin-resistant (mupA) and carried the lincosamide resistance gene lnuA, 
the first report of these resistance genes in an equine-derived isolate. We found that MSSA 
in addition to MRSA carry diverse virulence factors and can be pathogenic in horses.  
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